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Executive summary 
Introduction  
Operations Research and Impact Evaluation (ORIE) is led by Oxford Policy Management (OPM) in 
conjunction with three other UK-based institutions, the London School of Hygiene and Tropical 
Medicine (LSHTM), the Institute of Development Studies (IDS) and Save the Children UK (SCUK), 
and four Nigerian partners, the University of Ibadan, Kaduna Polytechnic, Ahmadu Bello University 
at Zaria (ABU), and the Food Basket Foundation International (FBFI). 
ORIE is funded by the Department for International Development of the UK Government and 
implemented in collaboration with the Government of Nigeria.  
This report presents the findings of the ORIE economic evaluation on the cost-effectiveness of the 
WINNN programme. The aim of this report is to evaluate the cost-effectiveness of the WINNN-
supported infant and young child feeding (IYCF) interventions and community-based management 
of acute malnutrition (CMAM) programme over the WINNN programme duration (2011–2017). The 
cost-effectiveness of the two interventions is evaluated from both a health services and a societal 
perspective. The health services perspective evaluates the costs incurred by health service 
providers in providing the intervention, including in this context costs incurred by WINNN and 
government. The societal perspective includes in addition costs incurred by health service users 
(i.e. patients and carers) and other members of society who may be directly or indirectly affected 
by the intervention (or no intervention). 
The audiences for this report are DFID, WINNN, the Nigerian government and civil society 
stakeholders. 
Separate reports provide detailed results of the costing of the WINNN outputs and a Value for 
Money (VfM) analysis of the overall WINNN programme. These reports complement the cost-
effectiveness analysis (CEA) findings in this report and will help provide a more comprehensive 
view on the VfM question of whether the best possible outcome was obtained with a given budget 
and with improvements in equity.  
The WINNN programme 
The WINNN programme is an ambitious £52 million, six-year DFID-funded programme (2011–
2017) to improve maternal, newborn and child nutrition in five states in northern Nigeria: Jigawa, 
Katsina, Kebbi, Yobe and Zamfara. WINNN is implemented by three partners: Save the Children, 
ACF and UNICEF.  
WINNN is designed to deliver three nutrition-specific interventions (micronutrient supplementation, 
IYCF interventions and a CMAM programme) that evidence has shown are effective and cost-
effective, while also supporting effective government coordination and planning for nutrition. The 
delivery of these interventions through government is expected to build government systems and 
capacity for implementation, and ultimately to institutionalise them within routine health care 
systems. This is expected to raise the political profile of undernutrition in Nigeria and to encourage 
government to support nutrition programmes. 
Based on the WINNN logframe, the outputs of the WINNN programme are as follows: 
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Output 1: Integration of micronutrient intervention into routine primary health services. This output 
is concerned with the delivery and integration of micronutrient interventions to pregnant women 
and children under five in routine primary health services.  
Output 2: Delivery of effective IYCF interventions in selected states and LGAs in northern Nigeria. 
This output is concerned with facility and community-based interventions focused on mothers of 
children under two and pregnant women, to improve IYCF practices through exclusive 
breastfeeding (EBF), weaning and complementary feeding.  
Output 3: Delivery of effective treatment for severe acute malnutrition (SAM) through local health 
systems in selected states and LGAs in northern Nigeria. This output is concerned with the 
provision of treatment for SAM via the CMAM programme through integrated primary health 
services. 
Output 4: Strengthening of nutrition coordination and planning mechanisms at national and state 
level. This output is related to more effective government planning and coordination in nutrition and 
related sectors at the federal and state levels, as well as building government commitment.  
Output 5: ORIE. The fifth output is a consortium independent of the three implementing partners 
and managed by Oxford Policy Management (OPM). ORIE is responsible for undertaking 
operations research and assessing the impact and effectiveness of the WINNN programme.  
In the interest of simplicity, throughout the report we refer to the second and third WINNN 
outputs—for which we evaluate cost-effectiveness in this report—as IYCF interventions (Output 2), 
and the CMAM programme (Output 3). 
Cost-effectiveness methodology 
CEA involves evaluating the impact of interventions on both costs and outcomes. It answers the 
question of whether the best possible outcome was obtained with a given budget, which allows 
decision-makers to compare interventions in terms of VfM. The methodology for the CEA was 
developed in ORIE’s inception phase, in consultation with various stakeholders, including WINNN 
Implementing Partners (IPs) and DFID, and informed by a focused literature review.  
CEA evaluates costs and outcomes in an incremental way, i.e. it evaluates the difference (or 
increment) in costs and difference in outcomes between a scenario with the intervention under 
study and a comparator (usually a non-intervention scenario).  
For the CMAM intervention, the analysis compares two scenarios. The first is one with WINNN-
supported CMAM-related services in focal LGAs (CMAM programme implemented scenario), in 
which children under five with SAM may have been admitted to CMAM facilities for treatment, 
received alternative treatment (outpatient or inpatient treatment without therapeutic feeding), or 
received no treatment/self-treatment. The second scenario (CMAM programme non-implemented 
scenario) includes children under five with SAM in non-CMAM programme intervention LGAs who 
may have received alternative treatment, or no treatment/self-treatment.  
For the IYCF intervention, the first scenario includes WINNN-supported (facility- or community-
based) IYCF-related services in focal LGAs. In this scenario, mothers of children under two may or 
may not have been exposed to facility- or community-based IYCF counselling. The second 
scenario includes mothers of children under two in LGAs not supported by WINNN who may or 
may not have been exposed to IYCF counselling in routine primary healthcare or other non-
WINNN programmes. For each scenario pathway, a number of possible child breastfeeding 
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outcomes can be experienced, such as being exclusively, predominantly or partially breastfed to 
not being breastfed at all.  
The ratio of the difference in costs and difference in outcomes is called the incremental cost-
effectiveness ratio (ICER). The ICER represents the additional cost that would be incurred to avert 
or gain one unit of the outcome measure. The resulting ICER of the WINNN-supported CMAM and 
IYCF interventions will reveal the optimal alternative (in relation to the comparator), which may be: 
same cost but more effective than the alternative, less expensive and at least as effective as the 
alternative, or more expensive while providing additional benefit that is worth the cost. This last 
scenario is the most common likely outcome of CEA analysis. The ICER is then evaluated against 
the willingness to pay for gain in one unit of the outcome. 
In this report, we calculate ICER ratios for two main outcome measures: disability-adjusted life 
years (DALYs) and lives saved. These two measures are widely used in economic evaluations of 
health interventions and are useful for directly comparing VfM in terms of health gain across 
different interventions. DALYs are primarily a measure of disease burden and combine years of life 
lost due to premature death and years of life lost due to disability. Lives saved is a measure of the 
difference between the number of deaths in the comparator scenario minus the number of deaths 
in the intervention scenario.  
The context of the study is five states in northern Nigeria: Jigawa, Katsina, Kebbi, Yobe and 
Zamfara. The time horizon for the costing covers most of the programme duration (September 
2011 to August 2016). The sixth and final year of the programme is not included due to the timing 
of this report. Various sources of information, including primary data collection and secondary 
sources, have been used to model the different parameters for the ICER calculation. First, primary 
results will be presented that are based on data sources and assumptions presented in the 
methods section. The implementation of the economic evaluation relied on various data sources 
and assumptions. Primary data was collected by ORIE and secondary sources of information 
included WINNN programme data and model assumptions based on published literature. Both 
WINNN IPs and the donor counterpart (i.e. DFID) were consulted in relation to key features of 
these data collection processes and sources of information. 
Findings  
Cost-effectiveness of the CMAM programme  
From a societal perspective, the cost per child in the CMAM programme implemented scenario 
was £14.6 while the cost was £1.9 per child in the CMAM programme not implemented scenario. 
Thus, the cost difference between the two scenarios was £12.6. DALYs per child in the CMAM 
programme implemented and not implemented scenarios were 30.1 and 29.7 respectively. The 
proportion of children alive was 81.4% in the CMAM programme implemented scenario compared 
to 80.3% in the CMAM programme not implemented scenario. Hence, the ICER for cost per 
DALY averted was £30.8 ($48.0) and for cost per life saved was £1,138 ($1,778). 
From a health services perspective, the cost per child in the CMAM programme implemented 
scenario was £12.9 while the cost was £1.5 per child in the CMAM programme not implemented 
scenario. The difference in costs was thus £11.4. This difference is slightly smaller than the cost 
difference in the societal perspective given that the health services perspective excludes the costs 
incurred by community volunteers (CVs) and caregivers. Hence, the ICER for cost per DALY 
averted was £27.8 ($43.4) and for cost per life saved was £1,028 ($1,606). 
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A sensitivity analysis done on the probability of accessing the WINNN-supported CMAM 
programme, using estimates from Simplified Lot Quality Assurance Sampling (LQAS)  Evaluation 
of Access and Coverage (SLEAC) coverage surveys, showed improved cost-effectiveness results, 
although the difference was not substantial: from a societal perspective we calculated a cost per 
DALY averted of £28.1 ($44.0) and cost per life saved of £1,039 ($1,622), while the figures were 
£25.2 ($39.4) and £934 ($1,458) respectively from a health services perspective. The difference in 
cost per DALY is around £3 ($4) cheaper than with the ORIE endline estimates while cost per life 
saved is around £95 ($150) cheaper. Thus, the ORIE survey estimates provide more 
conservative estimates of cost-effectiveness of the CMAM programme compared to using 
SLEAC estimates. 
Cost-effectiveness of the IYCF interventions  
 
The CEA for the IYCF intervention uses a difference-in-difference (DID) methodology in which the 
differences in costs and outcomes between the WINNN and non-WINNN intervention scenarios 
are assessed between baseline (2013) and endline (2016). The ICER is then calculated as a 
ratio of the DID estimates of costs and mortality outcomes.  
When using the societal perspective, the cost per mother (i.e. cost per mother reached times the 
probability of exposure to the IYCF interventions) at baseline was £2.90 and £2.22 for WINNN and 
non-WINNN intervention areas respectively. Hence, the difference in costs at baseline was £0.69 
per mother. At endline, the cost per mother was £8.54 and £4.19 for WINNN and non-WINNN 
areas respectively. Thus, the difference in costs at endline was £4.35 per mother. As a result, the 
DID cost estimate from a societal perspective was £3.66 per mother. When using a health 
services perspective, the DID cost estimate was £3.15 per mother.  
The predicted mortality at baseline using breastfeeding rates in the Lives Saved Tool (LiST) was 
the same for both WINNN and non-WINNN LGAs at 116.61 per 1,000 live births. At endline, the 
predicted mortality was 108.64 in WINNN areas and 113.83 in non-WINNN areas. Thus, the 
difference-difference estimate of mortality per 1,000 live births was 5.19 (or 0.00519 deaths 
averted per live birth) between non-WINNN and WINNN LGAs. 
The ICER for cost per life saved is then calculated as a ratio of the DID cost per mother estimate 
and the DID mortality outcome. From a societal perspective, the incremental cost per death 
averted is £706 ($1,102) and £607 ($947.9) from a health services perspective. As in the case 
of the CMAM programme, the ICER in the health services perspective is slightly lower due 
to the exclusion of costs borne by CVs.  
The LiST does not allow calculation of DALYs averted for the IYCF interventions. Thus, we 
assume 37 DALYs lost per premature death (as in case of the CMAM programme) to convert per 
life saved to per DALY averted. We estimate that the incremental cost per DALY averted for 
the WINNN IYCF interventions is £19.1 ($29.8) from a societal perspective and £16.4 ($25.6) 
from a health services perspective. The DALY estimate is based on the assumption that long-
term mortality and disability in children who were alive in the IYCF interventions model is similar to 
those who were alive in the CMAM model after recovering from an episode of malnutrition. This is 
a conservative estimate (i.e. DALYs experienced by children who were alive in the IYCF 
interventions model may be under-estimated) given that we expect the SAM condition to have a 
higher disability weight compared to other conditions affected by suboptimal breastfeeding.  
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Conclusions 
The cost-effectiveness results of the CMAM programme for the WINNN programme 
compare well with estimates in recent studies of CMAM programmes in northern Nigeria 
and elsewhere. Using a health services perspective, Wilford et al. (2012) estimated an ICER of 
US$42 per DALY averted and US$1,365 per life saved in Malawi. Similarly, Bachmann (2009) 
estimated an ICER of US$53 per DALY averted and US$1,760 per life saved in Zambia. From a 
societal perspective, Puett et al. (2013) estimated an ICER of US$29 per DALY averted and 
US$1,344 per life saved in southern Bangladesh. The lower estimates from southern Bangladesh 
are so because the model was assumed to be implemented by community workers, meaning that 
outpatient staff and overhead costs were not included. Finally, Frankel et al. (2015) estimated an 
ICER of US$30 per DALY averted and $1,117 per life saved in a recent study in northern Nigeria. 
The lower estimates in that case are likely explained by the different methodology used to estimate 
costs, which produced a lower cost per child treated, and different assumptions around programme 
coverage and mortality outcomes. 
The ICER per DALY averted of £30.8 ($48.0) from a societal perspective and £27.8 ($43.4) 
from a health services perspective suggest that the WINNN-supported CMAM intervention 
was ‘very cost-effective’ using the World Health Organization’s (WHO) CHOICE model 
threshold for cost-effectiveness. The WHO-CHOICE model suggests that if the ICER per DALY 
averted is below the value of gross domestic product (GDP) per capita then the intervention is 
‘very cost-effective’. The GDP per capita of Nigeria in 2015 was $2,617 according to the World 
Bank (World Bank, 2017); hence, the ICER per DALY averted is ‘very cost-effective’ in all 
analyses. 
The WINNN-supported CMAM programme is also considered to be cost-effective using 
other recent cost-effectiveness thresholds in the literature. A recent development in the 
literature is the cost-effectiveness threshold based on opportunity cost. This country-level threshold 
was proposed by Woods et al. (2016) – the authors combined the GDP per capita and the value of 
a statistical life to propose a threshold to reflect the health opportunity cost. Based on this study, 
the threshold range for Nigeria is $239 to $1,545. Hence, an intervention that costs more than the 
higher estimate of $1,545 per DALY averted is considered not cost-effective.  
There is a lack of existing ICER estimates in the global literature for similar IYCF 
interventions, limiting the comparison of the cost-effectiveness of the WINNN-supported 
IYCF interventions. The studies found in the focused literature review of IYCF interventions 
calculate cost per beneficiary measures but none of them evaluated long-term outcomes, either in 
terms of reduced mortality or morbidity.  
Using the approximation of 37 DALYs to convert per life saved to per DALY averted for the WINNN 
IYCF interventions, the ICER estimates calculated of £19.1 ($29.8) from a societal perspective 
and £16.4 ($25.6) from a health services perspective suggest that the WINNN-supported 
IYCF interventions were also ‘very cost-effective’ using the WHO-CHOICE model threshold.  
Both ICER measures, i.e. the cost per life saved and the cost per DALY averted, are lower 
for the IYCF interventions than the CMAM programme. This is to be expected, as preventative 
services such as the IYCF interventions usually represent better VfM and can help to reduce the 
need for a more expensive treatment. However, the CMAM programme remains very cost-effective 
and addresses a large disease burden, which brings significant health and economic benefits.  
The CMAM and IYCF interventions have much lower cost per DALY averted compared to 
many other interventions that are competing for the health care budget. For example, the 
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cost per DALY averted is $117 for family planning programmes, $922 for antiviral therapy (DFID, 
2011)and $94 for an integrated prevention campaign focused on diarrhoea, malaria and HIV 
(Marseille et al., 2014). 
Key lessons and recommendations 
The principle objective of this CEA was to assess the return on investment of the WINNN 
interventions, not to develop detailed operational recommendations. ORIE has produced a 
separate document, the Integrated Evaluation Report of the WINNN programme, which draws on 
evidence from across ORIE workstreams to fully draw out lessons learned and recommendations 
targeted toward specific stakeholder groups such as the Nigerian government, donors and 
programme implementers. The Integrated Report also draws on evidence from across ORIE 
workstreams to report on WINNN’s logframe indicators.  
However, a number of important lessons and recommendations do nevertheless emerge from the 
CEA and are outlined below. In addition to DFID, the WINNN programme and the Government of 
Nigeria, these will hopefully prove useful to any professionals involved in the design of nutrition-
specific and nutrition-sensitive programmes in Nigeria.  
Lessons 
1) The economic analysis of the WINNN programme has demonstrated that nutrition-
specific interventions in Northern Nigeria can be cost-effective.  
2) While both interventions were found to be cost-effective, we learnt that high-level 
programme delivery costs, including those incurred by the WINNN programme, make 
up a significant proportion of the total programme cost (see ORIE Costing report 
(2017) for detailed analysis of the programme costs). Funding bodies should work with 
local governments to assess ways of reducing these costs while building local 
capacity and transferring programme ownership to state governments to scale up 
these interventions to the population level.  
3) This study has important lessons for future CEAs. ORIE engaged the implementers 
early in the programme, which allowed for the development of survey tools that were 
tailored to the evaluation to provide robust data (see Quantitative Impact Evaluation of 
the WINNN Programme – Volume 1, 2017 on the effectiveness data). This also 
allowed investigators to pilot test and improve the data collection methods for within-
programme and follow-up data. As a result, compared to other economic studies of 
nutrition-specific interventions, this evaluation had to make fewer assumptions for the 
CEA.  
4) However, the cost-effectiveness estimates were constrained by the lack of data on 
health outcomes and particularly long-term ones such as children mortality. This 
should be planned for in future studies. This study also identified gaps in data in non-
intervention areas, such as the type and quantity of care received by children and their 
outcomes of care – this was overcome by making informed conservative assumptions 
based on the literature.  
5) Cost-effectiveness estimates were also constrained by the lack of long-term data on 
costs, which should equally be planned for in future studies. Data issues were also 
encountered in relation to programme-specific costs at state government level, with 
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data both challenging to obtain and having significant variations in estimates and 
quality. These issues can be overcome through structured and coordinated efforts 
between funding bodies and state governments to develop and/or improve 
programme-specific budgetary reporting mechanisms. 
6) Our study found that the cost-effectiveness estimates of nutrition-specific interventions 
varied based on the perspective of decision-making, and therefore it is important for 
future studies to plan data collection and present results from both the societal as well 
as health services perspective. 
Recommendations 
1) The cost-effectiveness evidence in this study found that both the CMAM programme 
and the IYCF interventions are cost-effective interventions for improving child health in 
northern Nigeria. This evidence is consistent with other studies conducted in Nigeria 
and other countries globally. This provides a basis to recommend that both 
programmes be considered by policy-makers and funding institutions as interventions 
that offer VfM in terms of improving child health outcomes. 
2) The coverage or exposure rate of the CMAM programme and the IYCF interventions is 
one of the determinants of cost-effectiveness. While both programmes were found to be 
cost-effective in this study, the coverage rates of both interventions remain low. The 
wider literature suggests that higher coverage level is likely to make the interventions 
even more cost-effective – this is because the fixed costs (such as high-level 
administrative expenditure) per child tends to reduce with increase in coverage due to 
economies of scale. Strategies to increase coverage should therefore be pursued by 
state governments in order to improve the cost-effectiveness of those interventions. 
Such strategies can include strengthening active case finding through a strong network 
of CVs, improving the access to IYCF-related services or improving the quality of 
service delivery.  
3) To further improve the cost-effectiveness of the CMAM programme, the programme 
should also aim to reduce default rates among enrolees, which will improve survival 
rates in children.  While this may require additional resources, the expected health 
gains in treatment completers will likely outweigh the additional costs. 
4) For the scale up of the CMAM programme and the IYCF interventions, resource 
implications must be considered carefully. This applies to both the resources required at 
higher-level as well as costs incurred at the level of health facilities and in the 
community. For instance, WINNN programme costs make up a large proportion of the 
cost of CMAM and IYCF interventions (i.e. 1/3rd of the total costs in case of the CMAM 
programme and at least 4/5th in case of the IYCF interventions). Therefore, the state 
governments should evaluate the budgetary capacity for scaling-up of these 
programmes. 
5) Given the challenges surrounding high-quality data in northern Nigeria, it is important to 
develop, at least at LGA level, a population-level monitoring and surveillance system on 
the nutritional status of children, their access to services, short-term treatment 
outcomes (such as rate of recovery after care and rate of recurrent episodes of 
malnutrition) and long-term outcomes (including mortality and disability rates), so future 
evaluations can benefit from robust data. 
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1 Introduction 
This report presents the findings of the ORIE economic evaluation of the cost-effectiveness of the 
WINNN programme. 
1.1 What is the WINNN programme? 
The WINNN programme is an ambitious £52 million, six-year, DFID-funded programme (2011–
2017) to improve maternal, newborn and child nutrition in five states in Northern Nigeria: Jigawa, 
Katsina, Kebbi, Yobe and Zamfara. WINNN is implemented by three partners: Save the Children, 
ACF and UNICEF.  
WINNN is designed to deliver three nutrition-specific interventions (micronutrient supplementation, 
IYCF interventions and a CMAM programme) that evidence has shown are effective and cost-
effective, while also supporting effective government coordination and planning for nutrition. The 
delivery of these interventions through government is expected to build government systems and 
capacity for implementation, and ultimately to institutionalise them within routine health care 
systems. This is expected to raise the political profile of undernutrition in Nigeria and to encourage 
government to support nutrition programmes. 
Based on the WINNN logframe, the outputs of the WINNN programme are as follows: 
Output 1: Integration of micronutrient intervention into routine primary health services. This output 
is concerned with the delivery and integration of micronutrient interventions to pregnant women 
and children under five in routine primary health services.  
Output 2: Delivery of effective IYCF interventions in selected states and LGAs in northern Nigeria. 
This output is concerned with facility and community-based interventions focused on mothers of 
children under two and pregnant women, to improve IYCF practices through EBF, weaning and 
complementary feeding.  
Output 3: Delivery of effective treatment for SAM through local health systems in selected states 
and LGAs in northern Nigeria. This output is concerned with the provision of treatment for SAM via 
the CMAM programme through integrated primary health services. 
Output 4: Strengthening of nutrition coordination and planning mechanisms at national and state 
level. This output is related to more effective government planning and coordination in nutrition and 
related sectors at the federal and state levels, as well as building government commitment.  
Output 5: The fifth output, ORIE, is a consortium independent of the three IPs and managed by 
OPM. ORIE is responsible for undertaking operations research and assessing the impact and 
effectiveness of the WINNN programme.  
In the interest of simplicity, throughout the report we refer to the second and third WINNN 
outputs—for which we evaluate cost-effectiveness in this report—as IYCF interventions (Output 2), 
and the CMAM programme (Output 3). More detail on the ORIE project is presented in Section 1.2. 
Note that the IYCF interventions consist of two component parts: one at the facility level- the f-
IYCF component and one at the community level-the c-IYCF component. Similarly, the CMAM 
programme also consists of two component parts: the treatment received at OTP facilities and 
treatment received at SC facilities. Throughout this report, the narrative refers to both the 
interventions as a whole or to its component parts as appropriate. 
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1.2 What is ORIE? 
The acronym ‘ORIE’ stands for Operations Research and Impact Evaluation. ORIE is responsible 
for undertaking operations research and assessing the impact of the WINNN programme. It is 
managed by OPM and consists of two other UK-based institutions – the London School of Hygiene 
and Tropical Medicine and the Institute of Development Studies – in conjunction with four Nigerian 
partners: the University of Ibadan, Kaduna Polytechnic, Ahmadu Bello University at Zaria, and 
Food Basket Foundation International. 
The ORIE project is composed of five workstreams as follows: 
1. Operations research; 
2. Impact evaluation; 
3. Economic evaluation; 
4. Evidence dissemination and uptake; and 
5. Supporting national researchers in nutrition. 
The level at which an intervention is focused determines the precise combination of methods used 
in the assessment of impact of each output of the WINNN programme. The CMAM and IYCF 
interventions are focused at the level of the LGA while micronutrient supplementation and effective 
government planning and coordination are focused at the level of the state and federal 
governments. For interventions implemented at the level of the LGA (i.e. IYCF counselling and the 
CMAM programme), a quasi-experimental design was used for impact assessment and decision 
modelling was used for economic evaluation. For other outputs of the WINNN programme, 
qualitative methods were used.  
This report relates to the economic evaluation workstream of the ORIE project, and focuses on the 
CMAM and IYCF interventions of the WINNN programme. This is because these two interventions 
have clearly defined and quantifiable outcomes and costs that can be evaluated within an 
economic evaluation framework. 
1.3 What is the aim of the economic evaluation? 
The three main objectives of the WINNN cost-effectiveness are: 
1. to estimate costs and cost-efficiency measures (cost per beneficiary) of WINNN-supported 
CMAM and IYCF interventions;  
2. to evaluate direct provider-related costs associated to WINNN Output 1 (Integration of 
micronutrient intervention into routine primary health services) and Output 4 
(Strengthening of nutrition coordination and planning mechanisms at national and state 
level); and 
3. to evaluate the cost-effectiveness of the WINNN-supported IYCF and CMAM interventions.  
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This report responds to the third objective. It brings together costs and outcomes to 
evaluate the cost-effectiveness of the IYCF interventions and the CMAM programme, i.e. it 
aims to answer the question of whether the best possible outcome was obtained with a 
given budget. Separate cost-effectiveness evaluations are conducted for these two interventions 
to allow decision-makers to separately assess the value of each intervention. Note that a more 
overarching analysis of VfM for the WINNN programme (including all its outputs), which 
also includes coverage of the concept of equity, will be presented as a separate report.  
The present report also includes a summary of the costing results used for this analysis. However, 
a more detailed explanation of the costing methods and findings has been delivered as a 
separate report, which aims to answer objectives 1 and 2 of the economic evaluation 
workstream.  
As in the costing report, the cost-effectiveness of the CMAM and IYCF interventions is evaluated 
from a health services and a societal perspective. The health services perspective evaluates the 
costs incurred by health service providers in providing the intervention, including in this context 
costs incurred by WINNN and government. The societal perspective includes in addition costs 
incurred by health service users. (i.e. patients and carers) and other members of society who may 
be directly or indirectly affected by the intervention (or no intervention). 
1.4 Background of the economic evaluation 
1.4.1 Stakeholders’ involvement 
Many stakeholders were involved in the design of each the five ORIE workstreams, including 
donors, IPs, the Nigerian Federal Ministry of Health and the National Primary Health Care 
Development Agency.  
During ORIE’s inception phase, and in order to understand the organisations active in the northern 
Nigerian nutrition landscape and the pathways between them, a map of the different actors active 
in this sector and their influence was drawn up by the ORIE team in stakeholder workshops. The 
workstream designs included the knowledge and main messages emerging from the stakeholder 
mapping workshop.  
Also, as mentioned in the inception report, the designs of all ORIE workstreams were constructed 
on the basis of ongoing discussion across workstreams, discussions with WINNN IPs, the literature 
review and the nutrition commitment audit, as well as a review of the literature and evidence 
specific to each workstream.  
The implementation of the economic evaluation relied on various sources of information, from 
primary data collected by ORIE to secondary sources of information, including WINNN programme 
data. Both WINNN IPs and DFID were consulted in relation to key features of these data collection 
processes and sources of information. In addition, throughout the implementation of the economic 
evaluation there has been a robust process of validation of the main parameters estimated with 
WINNN programme data, and incorporation of comments received from both WINNN IPs and 
DFID. Finally, internal and external quality assurance processes were also implemented before 
this report was finalised to ensure adequacy of methodology and estimations.  
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1.4.2 Departure from the inception report  
The inception report that was produced at the beginning of this evaluation in consultation with 
various stakeholders constitutes the key document of reference for this analysis (see Annex A for 
excerpts from Volume I and Volume II of the inception report that relate to the economic 
evaluation). The inception report was written following consultations with DFID, academics and 
Nigerian counterparts to ensure that the goals of this evaluation reflected the interests of different 
stakeholders. There has not been any major departure from the original inception plan. As stated 
in the inception report (Annex A), the full economic evaluation, which includes a CEA, concentrates 
primarily on the CMAM and IYCF interventions, which this report has done.  
The inception report also outlined the possibility of scoping full costing studies for WINNN outputs 
1 and 4. However, this was not implemented in the end due to limitations restricting the ability to 
scope WINNN contribution on those interventions using a quantitative approach. This is because 
these interventions are delivered state-wide and nationally (there is no WINNN LGA focus, as 
there is for the IYCF and CMAM interventions), while they also involve many other IPs and donors, 
from which expenditure data would have been very difficult to obtain. Thus, it was agreed that this 
would be outside the scope of the ORIE economic evaluation.  
1.5 Scope and structure of this report 
The report is organised as follows: 
Section 2 will present the overall approach of the economic evaluation as it applies to CEAs of 
both the WINNN-supported CMAM and IYCF interventions. This will include an introduction to the 
CEA approach used in the ORIE project, a description of the decision modelling method, an 
explanation of the rationale for the perspectives taken in the economic evaluation, and a general 
description of the costs and outcomes included in the analyses. 
Section 3 will present the cost-effectiveness of the WINNN-supported CMAM programme. This will 
include specific descriptions of the decision model used for the analysis, data sources for 
probabilities, costs and outcomes, and the results of the CEA of this intervention. 
Section 4 will present the CEA of the IYCF interventions and will follow the same structure as 
section 3.  
 Section 5 will summarise the main findings, compare our results to other CMAM and IYCF 
programmes, and include some points for discussion. 
Finally, section 6 provides key lessons deriving from findings as well as some recommendations.  
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2 Overall approach of the economic evaluation 
This section will introduce the overall approach of the economic evaluation, and in particular of the 
CEA covered in this report. While we have conducted separate CEAs of the CMAM programme 
and the IYCF interventions, there are several common areas and these are presented in this 
section. This will be followed by separate sections on the CEAs of the CMAM and IYCF 
interventions. 
2.1 What is CEA? 
Economic evaluation can be conducted in the following forms: 
1. Cost analysis, which evaluates the cost of delivering an intervention (this is presented in a 
separate report); and 
2. CEA, which brings together both costs and outcomes to allow assessment of the VfM of 
health care interventions. 
In resource-constrained health systems, particularly in developing countries, the allocation of 
resources between competing interventions requires evidence not only on effectiveness but also 
on cost-effectiveness. CEA involves evaluating the impact of interventions on both costs and 
outcomes. This allows decision-makers to compare interventions in terms of VfM to achieve 
maximum health gains for the population within limited resources.  
CEA is the most common method of economic evaluation in the literature (Drummond et al., 2005). 
This is an incremental analysis, i.e. it evaluates the difference (or increment) in costs and 
difference in outcomes between the intervention and the comparator (or scenarios A and B) (see 
Figure 1). The ratio of the difference in costs and difference in outcomes is called the ICER, which 
represents the additional cost that would be incurred to avert or gain one unit of outcome.  
Figure 1:  Overall CEA approach 
 
Source: Authors.  
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The ICER is then evaluated against a cost-effectiveness threshold (discussed later), which 
represents willingness to pay for an additional unit of outcome. If the ICER is below the threshold 
then the intervention is considered cost-effective. 
The main outputs of the economic evaluation of the CMAM programme are the cost per DALY 
averted and cost per life saved. The main output of the IYCF interventions evaluation is the cost 
per life saved due to the IYCF interventions. The DALY outcome is described later in this chapter. 
2.2 Use of the decision modelling approach in CEAs 
It is common practice in economic evaluations to use decision models to evaluate the cost-
effectiveness of interventions (Drummond et al., 2015). Decision modelling is a systematic 
approach to decision-making under conditions of uncertainty (Briggs et al., 2006). Decision models 
start by identifying the interventions (or scenarios) being compared. Figure 2 presents a general 
schematic of a decision tree model. The model starts from the left side of the figure with a choice 
between scenarios A and B. Conventionally, a choice node is represented by a dark squared box, 
and to the right of this choice node are the scenarios or treatments being compared.  
For each chosen scenario, one of a number of possible pathways will be followed by a child. An 
example of a pathway is that a child in scenario A may be admitted to an outpatient clinic followed 
by recovery. These pathways are presented on the right side of a circular node (called chance 
nodes or probabilistic nodes), which represent the fact that these pathways depend on 
probabilities. More specifically, if the probabilities of pathways 1, 2 and 3 in scenario A in Figure 2 
are 0.25, 0.35 and 0.40 then 25%, 35% and 40% of children will follow pathways 1, 2 and 3 
respectively. 
Subsequently, each pathway incurs costs during the process and has final outcomes (e.g. DALYs 
or survival probability), which are added up for all the pathways in both scenarios A and B to give 
total costs and total outcomes. Finally, the difference in costs and difference in outcomes are 
compared between scenario A and B to get the ICER (as in Figure 1).  
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Figure 2:  A schematic presentation of the decision tree modelling approach for CEA 
 
Source: Authors.  
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of developing countries, the perspective taken in an economic evaluation can be crucial. This is 
because the (direct and indirect) costs incurred by patients and their family members can in some 
contexts make up a significant part of the total cost. 
The argument for taking the societal perspective is that the burden of malnutrition and mortality 
has direct cost implications for the health system as well as the households, and therefore the aim 
of an intervention should be to reduce the cost burden on both while maximising health outcomes. 
The argument for taking a health services perspective is that the WINNN programme will be 
primarily funded through the health budget, meaning that the aim of the economic evaluation 
should be to identify interventions that maximise return on health sector investment. 
Previously published studies of CMAM have used either a health services perspective or a societal 
perspective. For instance, Wilford et al. (2012) conducted a cost per DALY analysis of the CMAM 
programme using a health services perspective, meaning no patient-related costs were included in 
the analysis. Similarly, Bachmann (2009) used the same approach and focused only on the health 
services perspective. However, Ashworth and Khanum (1997) used a societal perspective to 
include parent-related costs such as transport costs and wages lost by working parents.  
In our study, we will present results based on both the societal perspective and the health services 
perspective so that decision-makers have more information they can use in order to determine the 
cost-effectiveness of both the CMAM programme and the IYCF interventions. 
2.4 Costs in the CEA 
The perspective of the CEA determines the costs that are included in the analysis. The health 
services perspective includes programme costs incurred by WINNN as well as by state-level and 
LGA-level governments. In addition, health facility costs are included in the health services 
perspective, which include capital costs, staff costs and operational costs (see sections 3 and 4 for 
details). The societal perspective takes a broader approach to costing and includes, in addition to 
the costs included in the health services perspective, the costs incurred by CVs and caregivers, 
both in terms of their out-of-pocket expenses as well as the opportunity cost of their time. Sections 
3 and 4 (and the separate costing reports on the CMAM programme and the IYCF interventions) 
provide further details of these cost centres. 
Table 1:  Broad cost centres included in the CEAs 
Perspective Costs included 
Health services 
perspective 
WINNN programme costs 
State-level programme costs 
LGA-level programme costs 
Health facility costs  
Societal 
perspective 
All of the above, plus: 
CV costs (including out-of-pocket and opportunity costs) 
Caregiver costs (including out-of-pocket and opportunity costs) 
 
The time horizon used in the costing calculations covers most of the programme duration 
(September 2011 to August 2016). The sixth and final year of the programme is not included due 
to the timing of this report. 
The data used in the costing analysis come from various primary and secondary sources with 
different currencies and years. Thus, we convert every cost at every year to USD before bringing 
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all costs together in a single calculation. Cost calculations are done in USD as it is the best 
practice in the international literature of costing and CEA. However, final calculations in this report 
have been converted to GBP using an exchange rate USD/GBP of 1.56 (the average USD/GBP 
exchange rate for the period between Year 1 and Year 5, i.e. September 2011 to August 20161) to 
facilitate reporting using DFID’s official currency. In the main calculations we still present both GBP 
and USD figures in order to facilitate comparison with cost-effectiveness measures from other 
studies, which are usually presented in USD.  
2.5 Outcomes in the CEA 
DALY as outcome measure 
DALYs are primarily a measure of disease burden and have been used frequently in economic 
evaluations. The advantage of using a generic measure like a DALY is that a decision-maker with 
a broad health sector mandate can compare VfM across several health programmes. DALYs 
combine years of life lost due to premature death and years of life lost due to disability. DALYs for 
an intervention group can be represented as: 
DALY = Years of life lost due to premature death + Years lost due to disability 
The disability weight for SAM is 0.053 (Murray et al., 1996), which has been used in other 
economic evaluations of the CMAM programme (Wilford et al., 2012; Puett et al., 2013). Based on 
Frankel et al. (2015), the study used the estimate of 37 DALYs per death averted. Hence, the total 
DALYs gained by the CMAM programme (compared to the non-CMAM programme scenario) is 
calculated by multiplying the DALYs gained per death averted times the number of deaths averted. 
Lives saved as outcome of measure 
The number of lives saved is another commonly used outcome measure in economic evaluations 
of the CMAM programme. As above, this is calculated as the difference is the number of deaths in 
the no intervention scenario minus the number of deaths in the intervention scenario. This outcome 
is used in the evaluations of the CMAM programme and IYCF interventions. 
 
                                               
1 This average of the representative rates for the period September 2011 to August 2016 is taken from the International 
Monetary Fund (IMF).  
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3 Cost-effectiveness of the CMAM programme 
The aim of this chapter is to present the methods and results of the cost-effectiveness evaluation 
of the CMAM programme. We start by listing the existing international evidence on the cost-
effectiveness of CMAM. These studies will then be used later in the report to compare our methods 
and findings. Section 3.2 presents the structure of the CMAM programme cost-effectiveness 
model. Following this, section 3.3outlines the data sources and assumptions used to estimate the 
cost-effectiveness model, including the probabilities, costs and outcomes used in the analysis. 
Section 3.4.1then presents the results of the CEA. Finally, section 3.4.2 discusses the results and 
limitations of the study in light of the existing evidence on the cost-effectiveness of CMAM. 
3.1 Existing evidence on the cost-effectiveness of CMAM 
We identified five peer-reviewed studies reporting full cost-effectiveness analyses and two studies 
reporting only cost analyses (with or without partial reporting of outcomes) of interventions for 
severe malnutrition in children. Lessons drawn from these studies have been used to directly 
inform the methodology proposed in this document. These studies are listed here and summarised 
in Annex B.  
CEAs: 
1. Puett, C., Sadler, K., Alderman, H., Coates, J., Fiedler, J.L. and Myatt, M. (2013) ‘Cost-
effectiveness of the community-based management of severe acute malnutrition by 
community health workers in southern Bangladesh’. Health Policy and Planning, pp. 386-
399 
2. Tekeste, A., Wondafrash, M., Atene, G. and Deride, K. (2012) ‘Cost effectiveness of 
community-based and in-patient therapeutic feeding programs to treat severe acute 
malnutrition in Ethiopia’. Cost Effectiveness and Resource Allocation, 10(4), pp.1–10. 
3. Wilford, R., Golden, K. and Walker, D.G. (2012) ‘Cost-effectiveness of community-based 
management of acute malnutrition in Malawi’. Health Policy and Planning, 27(2), pp.127–
137. 
4. Bachmann, M.O. (2009) ‘Cost effectiveness of community-based therapeutic care for 
children with severe acute malnutrition in Zambia: decision tree model’. Cost Effectiveness 
and Resource Allocation, 7(2). 
5. Ashworth, A. and Khanum, S. (1997) ‘Cost-effective treatment for severely malnourished 
children: what is the best approach?’ Health Policy and Planning, 12(2), pp.115–121.  
In addition, we drew on the following CEA of CMAM in northern Nigeria: 
Frankel, S., Roland, M. and Makinen, M. (2015) ‘Cost-Effectiveness, and Financial Sustainability of 
Community-based Management of Acute Malnutrition (CMAM) in Northern Nigeria’. Field 
Exchange, 50, pp. 51–53. 
Cost analyses: 
1. Abdul-Latif, A.M.C. and Nonvignon, J. (2014), ‘Economic Cost of Community-Based 
Management of Severe Acute Malnutrition in a Rural District in Ghana’, Health, 6, pp. 886-
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8992. Purwestri, R.C., Scherbaum, V., Inayati, D.A., Wirawan, N.N., Suryantan, J., Bloem, 
M.A., Pangaribuan, R.V., Hoffmann, V., Biesalski, H.K., Qaim, M. and Bellows, A.C. (2012) 
‘Cost analysis of community-based daily and weekly programs for treatment of moderate and 
mild wasting among children on Nias Island, Indonesia’. Food and Nutrition Bulletin, 33(3), pp. 
207–216. 
A detailed description of these studies is included in Annex B. We will draw on the findings of these 
studies and compare our results with them in the discussion section of this chapter. 
Next we will present the methods and results of the economic evaluation of the CMAM programme 
in WINNN focal LGAs. 
3.2 Structure of the CMAM programme decision model 
The decision model compares the cost-effectiveness of the following two scenarios: CMAM 
programme implemented (scenario 1) and CMAM programme not implemented (scenario 2). 
Under each scenario, children follow different treatment pathways and there are different outcomes 
and costs. These are presented in the decision model (Figure 3) and described below.
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Figure 3:  Schematic representation of the CMAM programme decision tree model for the CEA 
 
Source: Authors. 
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Scenario 1: CMAM programme implemented 
In this scenario, children follow one of the following pathways: 
a. Admitted to CMAM facility for treatment 
b. Not admitted to CMAM  
i. Receive non-facility for treatment  
ii. Receive no treatment or self-treatment 
The above reflects the reality that only a proportion of the children under five with SAM who live in 
WINNN focal LGAs where the CMAM programme is implemented will actually access the CMAM 
programme; other children who were not admitted to a CMAM programme facility will either receive 
non-CMAM programme treatment or no treatment/self-treatment at all. This part of the pathway is 
determined by the [probability of treatment access] (described below in section 3.3.1). Non-
CMAM programme treatment includes any treatment for underlying illnesses received at a health 
centre (excluding therapeutic feeding) or traditional inpatient services (excluding therapeutic 
feeding). 
Children who were admitted to the CMAM programme facility can have one of the following 
outcomes: (a) recovered; (b) not recovered; (c) defaulted; (d) died in the Outpatient Therapeutic 
Programme (OTP) facility; (e) referred from OTP facility to stabilisation care (SC) facility. Children 
who were referred to an SC facility may then recover or die in a SC facility or may not recover (or 
default from care). This part of the pathway is determined by the [probability of treatment 
outcomes] (described below in section 3.3.1). Finally, children who did not die in the OTP or SC 
facility (including those who recovered, did not recover or defaulted) still face a risk of death after 
exiting the CMAM programme (see Figure 3). However, children who recovered in the OTP or SC 
facility have a much lower risk of death compared to other children. This part of the pathway is 
determined by the [probability of mortality outcome] (described below in section 3.3.1). 
Scenario 2: CMAM programme not implemented 
In this scenario, children follow one of the following pathways: 
a. Receive non-CMAM programme treatment 
b. Receive no treatment or self-treatment 
The above represents that children in the ‘CMAM programme not implemented’ scenario, i.e. those 
in LGAs not supported by WINNN or other CMAM programmes, may access non-CMAM 
programme treatment or receive no treatment/self-treatment. This part of the pathway is 
determined by the [probability of treatment access] (described below in section 3.3.1). As 
above, children receiving non-CMAM programme treatment or no treatment face a mortality risk in 
the follow-up period (Figure 3). This part of the pathway is determined by the [probability of 
mortality outcome] (described below in section 3.3.1). 
The model is then analysed by assigning probabilities to each pathway in the decision tree.2 The 
sources of these probabilities are described in the next section.  
                                               
2 An example of a pathway followed by a child in this model is: child admitted to CMAM programme followed by recovery 
followed by no mortality.  
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Next, DALYs (Devleesschauwer et al., 2014) and costs are assigned to each pathway (Bulti et al., 
2015; Bachmann, 2009). This is done by assigning costs as they are incurred during patient 
pathways. For instance, a patient who receives treatment at a CMAM facility and then recovers 
from SAM will incur costs in the model during treatment. DALYs are assigned at the end of the 
model depending on the mortality outcome, i.e. a child who received treatment at a CMAM facility 
and recovered from SAM and stayed alive is assigned to experience 37 DALYs (note that the 
DALYs methodology is explained in section 3.3.1.4). These costs and DALYs are then aggregated 
for all pathways within each scenario to calculate total costs and total DALYs for each scenario. 
Finally, the difference in costs and DALYs between CMAM programme implemented and non-
CMAM programme scenarios is calculated to estimate the incremental cost per DALY averted. The 
same approach is followed for lives saved – in this case, the total probability of being alive is 
calculated for each scenario, and the difference in probabilities represents the difference in lives 
saved. 
3.3 Data sources for the decision model 
This section will present the data sources and assumptions used in the decision model. These 
data, also called model parameters in this context, include the probabilities of each pathway in the 
decision model and the associated costs and outcomes. This section will identify the sources and 
assumptions used to obtain these model parameters. Table 2 summarises the data sources for all 
model parameters; these are subsequently described in detail. 
Table 2:  Data sources for model parameters used in the economic analysis 
Model parameters Data sources 
Probabilities used in the decision model 
Probability of use of treatment at 
CMAM facilities and non-CMAM 
programme treatment and no 
treatment/self-treatment 
ORIE endline survey [primary analysis] 
SLEAC survey [sensitivity analysis] 
Probability of treatment outcomes 
among CMAM facility users (including 
dying during CMAM facility treatment) 
WINNN programme service data for the CMAM programme 
intervention 
Probability of mortality in CMAM 
programme users after exiting from 
the CMAM programme (presented as 
mortality outcome in Figure 3) 
Follow-up survey of CMAM service users, conducted by Jos 
University (recovered in the OTP or SC facility) 
Model assumptions for other treatment outcomes, i.e. not recovered 
and defaulted 
Probability of mortality in children 
receiving no treatment 
Mortality estimated based on the mid-upper arm circumference 
(MUAC) score of SAM children before they received treatment 
(explained in section 3.3.1.3) 
Probability of mortality in children 
receiving non-CMAM programme 
treatment 
Assumed to be an average of mortality in the CMAM programme 
and mortality in children receiving no treatment 
Costs used in the decision model 
WINNN programme costs 
WINNN programme expenditure data for Year 1 to Year 5, broken 
down by states, outputs and cost categories  
State and LGA-level programme costs 
ORIE-conducted interviews with State Nutrition Officers (SNOs), 
Local Nutrition Officers (LNOs) and WINNN Local Technical 
Assistants (LTAs) in Jigawa, Katsina, Kebbi and Zamfara  
Health facility-level costs 
Various data sources were used for the calculations of these costs: 
Patient registration cards, UNICEF procurement data from WINNN 
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3.3.1 Probabilities in the decision model 
3.3.1.1 Probability of use of CMAM programme and non-CMAM programme treatment 
The ORIE endline survey, which was conducted in June 2016, provides the primary source of 
information by which we estimate some of the main parameters used in this economic evaluation, 
such as the probabilities of use of CMAM programme and non-CMAM programme treatment. This 
survey represents a panel of households, using the same households that were surveyed three 
years previously for the baseline (June 2013). Data were collected in WINNN focal LGAs 
(treatments) and in LGAs where WINNN has not operated (controls). It covered four states: 
Jigawa, Katsina, Kebbi and Zamfara. The sampling ensured that estimates are representative of 
treatment and control LGAs overall – i.e. across the geographical area that these LGAs cover – 
irrespective of the exact location of WINNN-supported activities within treatment LGAs. Further 
detail on the sampling methodology and sample size can be found in the ORIE quantitative impact 
evaluation report (Quantitative Impact Evaluation of the WINNN Programme – Volume 1, 2017). 
The main population of interest for child-level indicators in the quantitative impact evaluation is 
children aged 0–35 months. Given that the impact evaluation was interested in parameters 
estimated for children under five, the ORIE endline survey also administered a sub-set of 
questions on CMAM programme exposure for children who were 0–35 months at baseline (hence, 
35–59 months at endline), in addition to the targeted population of children aged 0–35 months at 
endline. Hence, we include all children 0–59 months in our estimations of CMAM programme 
parameters coming from the ORIE endline survey.  
Under the CMAM programme implemented scenario, the probability of use of the CMAM 
programme was based on the ORIE endline survey. This probability was calculated in treatment 
areas as the proportion of children aged 0–59 months whose main caregiver reported that the child 
was ever taken to a CMAM facility for treatment with Ready-to-Use Therapeutic Food (RUTF) or 
any therapeutic milk (F75/F100). Caregivers were shown showcards with pictures of those 
commodities so they could recognise them more easily. We assumed that a report of use of RUTF 
or therapeutic milks implied the child had accessed treatment at a CMAM facility in WINNN-
supported LGAs. The survey also established the undernutrition status of children at the time of 
the endline survey using different anthropometric measures. Since the decision model focuses on 
the population of children with SAM (and not the general population of children), we estimated the 
probability of use of the CMAM programme in children with SAM in treatment LGAs. In order to not 
restrict our sample size, we use a broad definition of SAM: children aged 6–59 months who have 
SAM at the time of the survey based on either weight-for-height Z-score <-3SD, and/or MUAC less 
than 115mm, and/or have visible oedema. The overall estimate of the use of the CMAM 
programme in SAM children aged 6–59 months in treatment LGAs was 16.7% (95% confidence 
interval = 11.8% to 23.1%).  
The other probabilities under the CMAM programme implemented scenario were also calculated 
with the ORIE endline data, using the sample of SAM children aged 6–59 months in treatment 
LGAs. The probability of receiving non-CMAM programme treatment was calculated as the 
proportion of children aged 0–59 months whose main caregiver reported that the child was ever 
and One Health Tool, ORIE-conducted interviews with SNOs, LNOs 
and LTAs, and the ORIE Health Facility Survey (HFS) 
CV costs HFS, patient registration cards  
Caregiver costs HFS, patient registration cards 
Costs of non-CMAM programme 
treatment 
Model assumptions based on Wilford et al. (2011) and WHO-
CHOICE estimates (explained in section 3.3.2.2)  
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taken to a CMAM facility for treatment with other treatment but RUTF or F75/F100 (e.g. Kwash 
Pap). The probability of receiving self-treatment or no treatment was calculated as the proportion 
of children aged 0–59 months whose main caregiver reported that the child never received 
treatment for malnutrition at the health facility. Probabilities under the CMAM programme not 
implemented scenario were calculated following a similar method as in the CMAM programme 
implemented scenario but in control LGAs.3 
Since the estimates coming from the ORIE sample are not estimates of CMAM programme 
coverage (coverage surveys usually include an active case finding method or a house-to-house 
screening of SAM cases in their sampling, which is very different to the ORIE sample), we also 
explore an alternative source of data for the probability of use of the CMAM programme (under the 
CMAM programme implemented scenario) – the SLEAC surveys available in northern Nigeria. 
SLEAC is a low-resource method of estimating coverage at the level of small (service delivery) 
units as well as larger (regional and national) levels. These surveys were conducted by Valid 
International in all four programme states in 2014 and again in Katsina and Kebbi in 2016. The 
average coverage estimate for the four states in 2014 was 36.6% (95% confidence interval = 
32.3% to 40.9%). The SLEAC estimates were used to conduct a sensitivity analysis of the 
‘probability of CMAM programme use’ parameter in the CEA. We note that SLEAC estimates were 
much higher than the ORIE endline survey estimates, but this is primarily because of the difference 
in study design mentioned earlier in this report.4 Thus, the ORIE survey estimates provide 
conservative estimates of the cost-effectiveness of the CMAM programme compared to using 
SLEAC estimates. However, SLEAC estimates were comparable to other published economic 
evaluations (see Wilford et al., 2012). 
                                               
3 As identified in the Quantitative Impact Evaluation of the WINNN Programme – Volume 1, 2017, there were spillover 
effects in terms of children in control LGAs accessing WINNN-supported interventions in treatment areas. We find that 
10.3% of SAM children aged 6–59 months in control LGAs accessed the CMAM programme, and 1.3% accessed other 
non-CMAM programme treatments such as Wash Pap. We assume that those caregivers of children who accessed 
CMAM facilities were motivated enough to have looked for any other alternative treatment had there not been any 
spillovers from the WINNN programme. Thus, we estimate an 11.5% probability of receiving non-CMAM programme 
treatment under the CMAM programme not implemented scenario.  
4 Specifically, SLEAC is a coverage survey that uses a two-stage sampling approach whereby villages (within wards of 
LGAs) are selected as primary sampling units in stage 1, followed by selection of the target population of SAM children 
(6–59 months old) within selected villages. 
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Table 3:  Probability of treatment use in the CMAM programme decision model 
Model parameters 
Estimate in WINNN states, 2016 
[source: ORIE endline survey] 
Average coverage estimates in 
WINNN states, 2014 [source: 
SLEAC surveys] 
CMAM programme 
implemented scenario 
(WINNN treatment LGAs)  
Admitted to CMAM programme 
(p1) 
16.7% 
 
36.6% 
Received non-CMAM 
programme treatment (p2) 
2.2% 1.7%* 
Received self-treatment or no 
treatment (p3) 
81.1% 61.7%* 
CMAM programme not 
implemented 
(WINNN control LGAs)  
Received non-CMAM 
programme treatment (p4) 
11.5% 
 
11.5% 
Received self-treatment or no 
treatment (p5) 
88.5% 88.5% 
* When using the SLEAC coverage estimates in the model, the probability of receiving non-CMAM programme or no/self-
treatment was based on the ORIE endline survey (and was adjusted so the sum of all probabilities is 1). 
3.3.1.2 Probability of treatment outcomes in the CMAM programme 
Once enrolled in the CMAM programme, children in an OTP facility can have one of the following 
treatment (discharge) outcomes, which are mutually exclusive and collectively exhaustive: 
recovered, died, defaulted, not recovered and referred from OTP facility to SC facility. 
The probabilities of these treatment outcomes (except referral from OTP facility to SC facility) were 
based on WINNN programme service data, which present monthly proportions by state of exit 
categories for SAM children accessing treatment at CMAM facilities overall. This means these data 
do not distinguish between OTP or SC facility treatment. We used Year 4 discharge data (i.e. the 
most recent) for the primary analysis. 
For the probability of referral to an SC facility, we assumed that 15% of SAM admissions at an 
OTP facility were referred to an SC facility. This assumption is based on the CMAM costing tool 
(FANTA, 2012) and is consistent with the assumptions made in the ORIE costing analysis report. 
Given that the WINNN programme service data provided were not broken down by type of service 
(i.e. OTP or SC facility) we needed to re-weight the exit category proportions found in the data to 
reach a sum of 100% with the inclusion of the 15% estimate for referral cases to SC facilities. The 
final parameters used in the model are presented in Table 4. 
In addition, children who were referred to an SC facility can have one of the following three 
outcomes: (a) recovered; (b) died; or (c) not recovered or defaulted. Proportions of each of these 
outcomes were also calculated using the WINNN programme service data, and a similar 
adjustment was made on proportions to reach a sum of 100%.  
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Table 4:  Treatment outcomes in CMAM programme 
Region 
Estimate [source: programme data, 
Year 4]* 
Estimate [source: programme data, 
Year 3]* 
Northern Nigeria 
(p6) Recovered = 73.4% Recovered = 65.2% 
(p7) Died = 2% Died = 1.6% 
(p8) Defaulted = 7.6% Defaulted = 15.3% 
(p9) Non-recovered = 2% Non-recovered = 2.7% 
(p10) Referred to SC facility from OTP 
facility = 15% 
Referred to SC facility from OTP facility = 
15% 
* The referral rate from OTP facility to SC facility was assumed to be 15%, and other rates were adjusted to reach a sum 
of 100% 
3.3.1.3 Probability of mortality outcomes 
Mortality following discharge among children who recovered in an OTP or SC facility was based on 
a preliminary analysis from the ORIE cohort study conducted by the University of Jos in two 
randomly selected LGAs in Jigawa. The study followed 410 children at six and 12 months after 
discharge from treatment at WINNN-supported OTP sites. The survey included a question on 
whether the child was ever treated at SC facility between discharge and the follow-up interview. 
We use this indicator to estimate mortality rates among children discharged from an OTP facility 
who had only been at an OTP facility and those who were also at SC facility. The mortality rates for 
the latter subgroup of children is used as a proxy for the post-discharge mortality rates of children 
recovered in an SC facility, even though the sample size is very low.  
It is found that among the children who had only visited OTP facilities, the mortality rate was 6.7% 
at six-month follow-up, while the post-discharge mortality rate was 11.5% in children who also 
visited an SC facility. Next, to obtain mortality in children who defaulted from the CMAM 
programme or did not recover (from OTP or SC facilities), we followed Wilford et al. (2012) and 
conservatively assumed this to be the same as mortality in SAM children receiving no treatment 
(see below). 
Mortality in children receiving no treatment was estimated using the approach recommended by 
Bulti et al. (2015). This approach uses the MUAC score of untreated SAM children and predicts 
mortality using the slope relationship between MUAC score and mortality – this slope is estimated 
using four published studies that followed children who received no treatment for SAM. The 
following slopes for reduction in mortality (per 1,000 children per year) were reported in these 
studies for a one-unit increase in MUAC score: -12.6 deaths (Briend and Zimicki, 1986); -39.4 
deaths (Briend et al., 1987); -31.1 deaths (Vella et al., 1994); and -23.5 deaths (Pelletier et al., 
1993). To implement this approach, we used the average MUAC score of untreated SAM children 
at the time of enrolment in the CMAM programme (i.e. before they started treatment). Using this 
MUAC score and the slope relationship described above, mortality in the untreated children was 
estimated. Our estimate was 20.25%, which is close to the estimate of 20.7% in Puett et al. (2013) 
and 20.8% in Bachmann (2009).  
Mortality in children receiving non-CMAM programme treatment in WINNN or non-WINNN areas 
was assumed to be the average of the overall mortality in the CMAM programme (i.e. 11.0%) and 
the mortality of no treatment (i.e. 20.25%, discussed below) – this was equal to 15.64%. This 
assumption was made due to lack of evidence on the mortality effect of a variety of prescribed or 
non-prescribed treatments (including home remedies) that children may receive for SAM. This 
assumption is slightly conservative compared to the literature; for instance, Wilford et al. (2011) 
assumed that mortality in children receiving non-CMAM programme care was 4% lower than those 
Cost-effectiveness of the WINNN Programme: Operations Research and Impact Evaluation 
© ORIE 19 
receiving no treatment, which is marginally less conservative compared to our estimate. The 
probability of mortality and related data sources are presented in Table 5.  
Table 5:  Mortality outcomes used in the decision model 
Mortality parameters Mortality estimate Sources 
Mortality in the CMAM programme users after exiting from the programme 
Recovered in OTP facility (p11) 
 
6.7% 
Jos University follow-up of children discharged 
from treatment at CMAM facilities 
Recovered in SC facility (p14) 11.5% 
Jos University follow-up of children discharged 
from treatment at CMAM facilities 
Not recovered or defaulted (p12, 
p13, p15) 
 
20.2% 
Following Wilford et al. (2012), mortality was 
conservatively assumed to be the same as for 
children receiving no treatment (assumed to be 
the same for OTP and SC children) 
Not admitted to the CMAM programme 
Received no treatment (p17) 20.2% 
Predicted mortality based on Bulti et al. (2015) 
using average MUAC score of 108.04 mm before 
treatment initiation 
Received non-CMAM 
programme treatment (p16) 
15.6% 
Average of CMAM programme mortality and no 
treatment mortality 
3.3.1.4 Calculating total probability and DALYs for each branch of the decision tree  
Next we bring together all the probabilities discussed in the above sub-sections. These 
probabilities are then multiplied to calculate the total probability of each branch in the decision tree 
and the probability of survival and the expected DALYs. Finally, the DALYs and survival 
probabilities are summed for CMAM programme implemented and not implemented scenarios. 
Note that all calculations are expressed in per child terms. 
Table 6 shows the calculations for the CMAM programme implemented and not implemented 
scenarios. Column A represents the overall path probability for each branch of the decision tree – 
this is the same as was presented in Table 3 (however, it is now expressed on a probability scale, 
i.e. 16.7% in Table 3 is expressed as 16.7/100 = 0.167).  
Column B represents the probability of survival (i.e. not dying). For children who received non-
CMAM programme treatment or no treatment, this is based on Table 5 (e.g. probability of survival 
in children receiving no treatment is 0.798 in Table 7, which is equal to 1 – 0.202 [or 20.2%] in 
Table 5). For children who enrolled in the CMAM programme, it is slightly more complicated to 
obtain the probability of survival (this relates to 0.890 in Table 6). This is because the survival 
probability for children receiving CMAM programme treatment is based on the probability of 
treatment outcome (e.g. recovered or defaulted) and the conditional probability of mortality given 
the treatment outcome. Calculations are presented in Table 7. The table shows that 73.4% of 
children who received care at an OTP facility had recovered (see Table 4 for the source), and 
93.3% of these children (who had recovered in OTP facilities) survived (see Table 5 for the source, 
i.e. 6.7% died and the remaining survived, so 100% – 6.7% = 93.3%). These probabilities were 
summed to arrive at 0.890 survival probability for children who enrolled in the CMAM programme.  
Next, we calculate the total survival probability for each branch of the decision tree by multiplying 
columns A and B in Table 6 to arrive at the total survival probability for each pathway (column C). 
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These survival probabilities in column C were then summed to arrive at the total survival probability 
for the CMAM programme implemented scenario (= 0.814) and the CMAM programme not 
implemented scenario (=0.803). These survival probabilities represent the proportion of children 
who are expected to be alive in each scenario. The difference between these proportions (=0.011) 
represents the difference in lives saved by the CMAM programme implemented scenario. This is 
used as the denominator in the calculation of incremental cost per life saved. 
Since children who survived were expected to experience 37 DALYs (based on Frankel et al., 
2015), column C was multiplied by 37 to arrive at column D (i.e. expected DALYs experienced per 
child). Finally, DALYs were summed for the CMAM programme implemented scenario to arrive at 
30.12 DALYs per child. For the CMAM programme not implemented scenario, this was equal to 
29.71 DALYs.  
Table 6:  Calculations of probabilities of outcomes and expected DALYs per child for 
the CMAM programme implemented and the CMAM programme not implemented scenarios 
Treatment 
scenarios  
Probability of 
treatment use 
(A)* 
Probability of 
survival of each 
pathway 
(B)ǂ 
Total survival 
probability 
(C) 
Expected DALYs 
experienced per 
child 
(D)ǂ 
CMAM programme implemented scenario 
Received CMAM 
programme 
treatment 
0.167 0.890 0.149 5.50 
Received non-
CMAM programme 
treatment 
0.022 0.844 0.019 0.69 
Received no 
treatment 
0.811 0.798 0.647 23.93 
TOTAL 1 - 0.814 30.12 
CMAM programme not implemented scenario 
Received non-
CMAM programme 
treatment 
0.115 0.844 0.097 3.59 
Received no 
treatment 
0.885 0.798 0.706 26.12 
TOTAL 1 - 0.803 29.71 
* This is the same as the probability of treatment use (see section 3.3.1.1 and Table 3). 
ǂ This is the product of column C x 37 DALYs. 
Table 7:  Treatment outcomes and survival probabilities for children who enrolled in 
the CMAM programme 
Treatment outcomes in 
children who enrolled in 
the CMAM programme 
Probability of 
CMAM programme 
treatment 
outcomes 
(E)* 
Probability of survival 
for each CMAM 
programme treatment 
outcome  
(F) 
Total survival 
probability 
(G = E x F) 
Recovered in OTP facility 0.734 0.933 0.685 
Defaulted in OTP facility 0.076 0.798 0.061 
Non-recovered in OTP facility 0.020 0.798 0.016 
Died in OTP facility 0.020 0.000 0.000 
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Referred to SC facility    
Recovered 0.130 0.885 0.115 
Defaulted/not recovered in 
SC facility 
0.017 0.798 0.014 
Died in SC facility 0.003 0.000 0.000 
Total for children enrolled 
in CMAM programme 
1 - 0.890 
* Column E is based on Table 4, which presents treatment outcomes in the CMAM programme. Column F is the 
complement of Table 5, i.e. 1 minus mortality estimate. 
3.3.2 Costs in the CMAM model 
The cost per child treated were estimated at the various CMAM programme centres before 
bringing them together for an overall cost per child treated estimate. We estimate costs using both 
health services and societal perspectives to provide a better understanding of the budgetary costs 
of the programme. There are three levels at which costs are incurred in the provision of the CMAM 
intervention:  
1. Health facility costs: These are all costs that are directly incurred in delivering an 
intervention to an individual in the health facility—in this case, treating children aged under 
five with SAM through OTP and SC centres. These are sometimes referred to as treatment 
costs. Such costs comprise: i) medicines including RUTF, F75/F100 and other routine 
medicines for treatment at OTP and SC facilities; ii) health worker inputs—the time spent 
by different cadres of health workers on delivering the intervention; and iii) a proportion of 
overhead costs attributable to treatment delivered within the CMAM facility. 
2. Community: These are costs incurred by CVs, who are recruited, trained and supervised 
by WINNN to support at OTP facilities. CVs receive stipends to cover training and meeting-
related costs but are not generally remunerated for their time. The second group at the 
community level is the caregivers of children with SAM, who incur costs in accessing 
CMAM-related services in terms of their time and expenses spent travelling to and from 
and waiting at health facilities. 
3. Higher-level programme: These are costs incurred at a ‘higher level’ than the health 
facility or patient; that is, money that funds activities at the national, state and LGA levels 
that enables the effective implementation of the CMAM programme. Two broad groups 
incur these costs: i) the WINNN programme; and ii) State and LGA government. Broad 
categories of activities include training, social mobilisation, monitoring and evaluation, and 
planning and coordination.  
Each cost level and the methodology for its calculation is explained in detailed in the ORIE costing 
report (ORIE Costing Report, 2017). Table 8 shows the estimates of the cost per child treated of 
the various cost centres of the CMAM intervention.  
Table 8:  Cost per child treated by type of service and cost centre 
  CMAM programme overall 
Cost centre GBP USD % 
Higher-level costs 30.4 47.5 36% 
WINNN programme 27.2 42.5 33% 
State and LGA 3.2 5.0 4% 
Health facility-level costs 44.3 69.2 53% 
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RUTF and F75/F100 29.2 45.6 35% 
Other medicines 0.6 0.9 1% 
Health worker time 7.7 12.1 9% 
Facility overheads 6.8 10.5 8% 
CV costs 1.9 3.0 0.0 
Expenses 0.6 0.9 0.0 
Opportunity cost 1.3 2.1 0.0 
Caregiver costs 7.1 11.0 8% 
Expenses 4.5 7.1 5% 
Opportunity cost 2.5 4.0 3% 
Total: Health services perspective 74.8 116.7 89% 
Total: Societal perspective 83.7 130.7 100% 
1/ Using an exchange rate of 1.56, calculated as the average of representative rates for the period September 
2011 to August 2016 (Source: IMF) 
3.3.2.1 Costs of CMAM programme treatment in the decision model 
For the CEA, the overall costs explained above were also estimated for each pathway in the 
decision model.  
Table 9 brings together the CMAM programme costs per child estimated above and shows costs 
per child for those children who received treatment at a CMAM facility, along with associated path 
probabilities. Total costs per child treated using the CMAM programme pathway is £84.94. Note 
that due to rounding in the costs calculations of the CMAM programme pathway (where costs are 
weighted based on the probability of the treatment outcome), the total of £84.94 does not 
correspond exactly to the overall figure of costs per child presented in Table 8 (£83.7), although 
the difference is marginal and does not affect our overall estimates. 
During treatment at OTP facilities, costs were higher for children who received treatment at a 
CMAM facility but did not recover, followed by children who recovered after receiving treatment. 
Costs were lower for children who defaulted or died during treatment at OTP facilities because 
they received only part of their CMAM programme treatment. Costs per child for those referred to 
SC facilities were the most expensive since these children incurred costs during treatment at OTP 
facilities and then in treatment of associated complications in inpatient facilities. Also, the human 
resource model at SC facilities is very different to that at OTP facilities; SC centres usually operate 
seven days a week, with relatively more qualified staff, given the level of care required, which also 
has implications in terms of costs. 
Table 9:  Calculations of costs per child treated in the CMAM programme 
Treatment outcome in 
children enrolled in the 
CMAM programme 
Cost per child 
treated in CMAM 
facility (A) 
Probability of 
treatment outcomes in 
CMAM programme  
(B)* 
Cost of the outcome 
pathway 
C=(A x B) 
Recovered (c1) £73.38 0.734 £53.89 
Died in OTP facility (c2) £50.24 0.020 £0.99 
Defaulted (c3) £54.34 0.076 £4.12 
Non-recovered (c4) £88.31 0.020 £1.77 
Referred to SC facility  
Survived (c5) £161.77 0.147 £23.70 
Died (c6) £137.24 0.003 £0.47 
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*This is the same as column E in Table 7.  
Calculations were made in USD and then converted to GBP using an exchange rate of 1.56, calculated as the average 
of representative rates for the period September 2011 to August 2016 (Source: IMF). 
3.3.2.2 Costs of non-CMAM programme treatment in WINNN and non-WINNN LGAs 
As described in section 3.3.1.1 and Table 3, 11.5% and 2.2% of SAM children accessed non-
CMAM programme treatment in non-WINNN and WINNN LGAs respectively. Using the ORIE 
endline data, we assume that 7.8% of the above children receive inpatient care while all children 
were assumed to receive outpatient care at (non-CMAM programme) primary health centres. 
Following Wilford et al. (2011), we also assumed that outpatient consultations at primary health 
centres included three visits. The unit cost of a health centre visit was based on the WHO-CHOICE 
estimate of a visit to an outpatient health facility in Nigeria, inflated to the year 2016. In addition, 
these children incurred caregiver costs for three visits. Finally, consistent with the literature, 
children receiving no treatment were assumed to incur no cost. We bring all these assumptions 
together in Table 10 and estimate costs per child for the full CMAM programme pathway.  
Table 10:  CMAM programme cost per child, outcome probabilities and cost in children 
under the CMAM programme implemented and not implemented scenarios 
Care pathway 
Cost per child 
(A) 
Probability of 
CMAM 
programme 
pathway 
(B) 
Total cost of care 
pathway 
(A x B) 
CMAM programme implemented scenario 
CMAM programme treatment 
received 
£84.94* 0.167 £14.19 
Non-CMAM programme 
treatment received (c7) 
£16.53 
 
0.022 £0.37 
No treatment (c8) £0 0.811 £0 
Total - 1 £14.55 
CMAM programme not implemented scenario 
Non-CMAM programme 
treatment received (c7) 
£16.53 0.115 £1.90 
No treatment (c8) £0 0.885 £0 
Total - 1 £1.90 
*This is the sum of costs in column C in  
Table 9. We note that this is slightly higher than the total cost reported in the costing report (£83.7) because here costs 
are weighted based on the probability of treatment outcome. 
Calculations were made in USD and then converted to GBP using an exchange rate of 1.56, calculated as the average 
of representative rates for the period September 2011 to August 2016 (Source: IMF). 
3.4 Results of the CMAM programme CEA 
This section presents the results of our CEA of the CMAM programme. First, primary results are 
presented that are based on data sources and assumptions presented in the methods section. 
This will be followed by the results of sensitivity analyses that are based on alternative data 
sources and assumptions outlined in the method section and again summarised in the results 
section. 
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3.4.1 Results of the primary CEA of the CMAM programme 
Table 11 presents the results of our CEA of the CMAM programme in WINNN focal LGAs from the 
societal perspective. The table shows that the cost per child in the CMAM programme 
implemented scenario was £14.6 while the cost was £1.9 per child in the CMAM programme not 
implemented scenario (see Table 10 for the calculations). Hence, the cost difference between the 
two scenarios was £12.6. Next, the DALYs per child in the CMAM programme implemented and 
the CMAM programme not implemented scenarios were 30.1 and 29.7 respectively (see Table 7 
for the calculations). The proportion of children alive was 81.4% in the CMAM programme 
implemented scenario compared to 80.3% in the CMAM programme not implemented scenario. 
Finally, the ICER for cost per DALY averted was £30.8 ($48.0) and for cost per life saved was 
£1,138 ($1,778). 
Table 11:  Cost-effectiveness results of the CMAM programme in WINNN focal LGAs 
(societal perspective) 
Scenarios 
Cost (GBP) per 
child* 
DALYs per childƗ Proportion aliveƗ 
CMAM programme implemented 
scenario ǂ 
£14.55 30.12 81.40% 
CMAM programme not 
implemented scenario 
£1.90 29.71 80.28% 
Difference £12.65 0.411 1.11% 
 
 
Cost per DALY 
averted 
Cost per life saved 
ICER - 
£30.77 
($48.04) 
£1138.44 
($1,777.55) 
ǂ Note that in the CMAM programme implemented scenario, not all SAM children use CMAM programme treatment (see 
Table 3). 
* See Table 10 for detailed calculations. 
Ɨ See Table 6 for detailed calculations. 
Calculations were made in USD and then converted to GBP using an exchange rate of 1.56, calculated as the average 
of representative rates for the period September 2011 to August 2016 (Source: IMF). 
Table 12 shows the results from a similar analysis using a health services perspective. Costs per 
child in the CMAM programme implemented and not implemented scenarios were £12.9 and £1.5 
respectively. The difference in costs is £11.4, which is similar to but slightly smaller than the cost 
difference in the societal perspective. This is because, under a health services perspective, the 
costs incurred by CVs providing CMAM services and caregivers are excluded from the analysis, 
which reduces the CMAM programme costs. Finally, the ICER for cost per DALY averted was 
£27.8 ($43.4) and for cost per life saved was £1,028 ($1,606). 
Table 12:  Cost-effectiveness results of CMAM programme in WINNN focal LGAs (health 
services perspective) 
Scenarios 
Cost (GBP) per 
child 
DALYs per child Proportion alive 
CMAM programme implemented 
scenario 
£12.92 30.12 81.40% 
CMAM programme not 
implemented scenario 
£1.49 29.71 80.28% 
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Difference £11.43 0.411 1.11% 
  
Cost per DALY 
averted 
Cost per life saved 
ICER - 
£27.80  
($43.40) 
£1028.45 
$1,605.81 
Calculations were made in USD and then converted to GBP using an exchange rate of 1.56, calculated as the average 
of representative rates for the period September 2011 to August 2016 (Source: IMF). 
3.4.2 Results of the sensitivity analyses of the cost-effectiveness of the CMAM 
programme 
The following cost-effectiveness estimates in Table 13 and Table 14 show the results of a 
sensitivity analysis of the ‘probability of CMAM programme use’ parameter, i.e. the probability of 
children in WINNN focal LGAs accessing the CMAM programme. Results presented previously 
were based on the ORIE endline survey. However, as was described in section 3.3.1.1, these 
parameters are not coverage estimates per se and thus we explored the use of alternative 
parameters based on the SLEAC coverage surveys to evaluate how robust our results are to those 
changes.  
As expected, cost-effectiveness results from both a societal and a health services perspective are 
improved when using the higher estimates for access to CMAM programme coming from the 
SLEAC surveys. This is basically explained by the fact that the proportion of children who will be 
affected by a lower mortality through accessing CMAM programme treatment is increased, while 
the costs of CMAM programme treatment remain the same. However, the differences between 
estimates are not substantial: with SLEAC estimates, the cost per DALY averted is around £3 ($4) 
cheaper than with the ORIE endline estimates while cost per life saved is around £95 ($150) 
cheaper, for both the societal and health services perspectives. Thus, the ORIE survey estimates 
provide more conservative estimates of the cost-effectiveness of the CMAM programme compared 
to using SLEAC estimates. 
Table 13:  Sensitivity analysis of ‘probability of CMAM programme use’ parameter using 
SLEAC surveys’ coverage estimates in WINNN states (societal perspective)* 
Scenarios 
Cost (GBP) per 
child* 
DALYs per childƗ Proportion alive 
CMAM programme implemented 
scenario 
£32.26 30.79 83.21% 
CMAM programme not 
implemented scenario 
£1.92 29.71 80.28% 
Difference £30.34 1.08 2.92% 
  Cost per DALY 
averted 
Cost per life saved 
ICER - 
£28.07 
($43.83) 
£1038.53 
($1,621.55) 
* In this sensitivity analysis, the source of data on access to the CMAM programme was based on the SLEAC survey 
instead of the ORIE endline survey. Calculations were made in USD and then converted to GBP using an exchange rate 
of 1.56, calculated as the average of representative rates for the period September 2011 to August 2016 (Source: IMF). 
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Table 14:  Sensitivity analysis of ‘CMAM programme use’ parameter using SLEAC 
surveys’ coverage estimates in WINNN states (health services perspective)* 
Scenarios 
Cost (GBP) per 
child* 
DALYs per childƗ Proportion alive 
CMAM programme implemented 
scenario 
£28.79 30.79 83.21% 
CMAM programme not 
implemented scenario 
£1.51 29.71 80.28% 
Difference £27.29 1.08 2.92% 
  Cost per DALY 
averted 
Cost per life saved 
ICER - 
£25.24 
($39.41) 
£933.99 
($1,458.32) 
* In this sensitivity analysis, the source of data on access to the CMAM programme was based on the SLEAC survey 
instead of the ORIE endline survey. 
Calculations were made in USD and then converted to GBP using an exchange rate of 1.56, calculated as the average 
of representative rates for the period September 2011 to August 2016 (Source: IMF). 
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4 Cost-effectiveness of the IYCF interventions 
The aim of this chapter is to present the methods and results of the cost-effectiveness evaluation 
of the WINNN-supported IYCF interventions. We start by listing the existing international evidence 
on economic evaluations of IYCF interventions. Section 4.2then presents the structure of the IYCF 
interventions cost-effectiveness model. Following this, section 4.3 sets out the data sources and 
assumptions used to estimate the cost-effectiveness model, including the probabilities, costs and 
outcomes used in the analysis. Section 4.4 presents the results of our CEA. 
4.1 Existing evidence on the cost-effectiveness of the IYCF 
interventions 
We identified two peer-reviewed studies reporting only cost analyses of IYCF interventions. These 
two studies are: 
1. Nkonki, L.L., Daviaud, E., Jackson, D., Chola, L., Doherty, T., Chopra, M. et al. (2014) 
‘Costs of Promoting Exclusive Breastfeeding at Community Level in Three Sites in South 
Africa’. PLoS ONE 9(1).  
2. Chola, L., Nkonki, L., Kankasa, C., Nankunda, J., Tumwine, J. et al. (2011) ‘Cost of 
individual peer counselling for the promotion of exclusive breastfeeding in Uganda’. Cost 
Effectiveness and Resource Allocation 9(11).  
Further details of these studies are included in Annex C. We will compare our results with them in 
the discussion section of the present chapter. 
Next we will present the methods and results of the economic evaluation of the IYCF interventions 
in WINNN LGAs. 
4.2 Structure of the IYCF interventions decision model 
In general, the methodology of economic analysis of the IYCF interventions is similar to that of the 
CMAM programme. Both analyses use decision models that represent alternative pathways for the 
interventions being compared. The IYCF interventions aim to influence breastfeeding practices and 
in turn have an impact on mortality outcomes. Since the IYCF interventions were also available in 
non-WINNN areas through other programmes, this analysis used a DID approach. More 
specifically, we assessed the breastfeeding rates at baseline and endline in WINNN implemented 
and not implemented areas. These rates are assessed for the following four age groups: <1 
month, 1 to 5 months, 6 to <12 months and 12 to <23 months. Based on these breastfeeding rates, 
we projected the mortality outcome (using the LiST, which will be described in more detail later) at 
baseline and endline for WINNN and non-WINNN areas. Finally, the change in mortality outcome 
(between baseline and endline) is calculated for WINNN areas (diffW) and non-WINNN areas (diffN) 
– the difference between these changes (i.e. diffW minus diffN) is the impact of the IYCF 
interventions on mortality (i.e. the estimate of deaths averted). Similarly, the DID estimate of cost 
was calculated by applying the cost of the IYCF interventions at baseline and endline in WINNN 
and non-WINNN areas. Finally, the ratio of the DID estimate of cost and of mortality outcome is 
used to obtain the ICER (i.e. incremental cost per death averted). Below we describe the economic 
analysis in more detail. 
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Figure 4:  Schematic representation of the IYCF interventions decision tree model for cost-effectiveness analysis 
 
* Mortality outcomes were based on the LiST. 
Source: Authors.
Population of interest
Intervention and 
comparator Exposure to IYCF counselling Age of child IYCF practices Mortality outcomes
Lives
Child is exclusively breastfed
Dies
Lives
Child is predominately breastfed
Dies
Child <1 month
Lives
Child is partially breastfed
Dies
Lives
Child is not breastfed
Dies
Mother is exposed to IYCF counselling Child 1-5 months as above
Lives
WINNN implemented Child receives 3 IYCF practices
Dies
Child 6-23 months
Lives
Child does not receive 3 IYCF practices
Dies
Children under 2
Pop(<2yrs)
Mother is not exposed to IYCF counselling as above
WINNN not implemented as above
3 IYCF practices for children 6-23 
months are: continued breastfeeding, 
appropriate quantity and diversity of diet
(p1) 
(p2) 
(p3) 
(p4) 
(p5) 
(p6) 
(p7) 
* 
* 
* 
* 
* 
* 
(c1-c3) 
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The population of interest for the IYCF interventions is children under the age of two years. A 
decision tree model (see Figure 4) is developed around the IYCF interventions exposure 
pathways. The decision model compares the cost-effectiveness of the following two scenarios: the 
IYCF interventions are implemented (scenario 1) and the IYCF interventions are not implemented 
(scenario 2). Conventionally, a choice node is represented by a dark squared box, and to the right 
of this choice node are the scenarios or treatments being compared.  
For each chosen scenario, one of a number of possible pathways will be followed by a child. An 
example of a pathway is that a child in scenario A may be admitted to a programme followed by a 
positive outcome. These pathways are presented on the right side of a circular node (called 
chance nodes or probabilistic nodes), which represent the fact that these pathways depend on 
probabilities. 
In the case of the IYCF interventions model, the proportion of children assigned to each pathway 
or branch is based on data from the ORIE quantitative endline survey (Quantitative Impact 
Evaluation of the WINNN Programme – Volume 1, 2017). The final mortality outcome is then 
calculated using the LiST (described later) and then aggregated for WINNN and non-WINNN 
scenarios before and after the implementation of the IYCF interventions. The difference in costs 
and mortality outcomes between the WINNN IYCF interventions implemented and WINNN IYCF 
interventions not implemented scenarios will be used to estimate the incremental cost per death 
averted.  
Costs are assigned as they are incurred during the pathway. For instance, a mother may receive 
IYCF counselling and then practice EBF. This will incur cost in the model when she is exposed to 
IYCF-related services. The mortality outcome for children is evaluated at the end of each pathway. 
These costs and mortality are then aggregated for all pathways within each scenario to calculate 
total costs and total mortality for each scenario. Finally, difference in costs and mortality between 
the IYCF interventions and the no IYCF interventions scenarios is calculated to estimate the 
incremental cost per life saved (or death averted). 
The decision model is described below. 
Scenario 1: WINNN IYCF interventions implemented  
In this scenario, children have one of the following exposure outcomes: 
a. Mother exposed to IYCF counselling 
b. Mother not exposed to IYCF counselling 
The above reflects that only a proportion of children who live in areas where WINNN’s IYCF 
interventions were implemented will actually be exposed to IYCF counselling. The definition and 
probability of exposure is presented later in the report (see [probability of exposure to the IYCF 
interventions] in section 4.3.1). 
Next, we evaluated the outcome of interest for the IYCF interventions, i.e. breastfeeding rates. 
These were evaluated for mothers exposed to the IYCF interventions as well as those not exposed 
to the IYCF interventions. The breastfeeding outcome was evaluated based on the age of the child 
because the recommended breastfeeding practices depend on the age. Hence, the following 
breastfeeding outcomes were evaluated based on the age: 
i. Child <1 month 
 EBF: Proportion of infants receiving only breastmilk during the previous day  
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 Predominantly breastfed: Proportion of infants receiving only breastmilk plus water 
and/or other non-milk liquids during the previous day 
 Partially breastfed: Proportion of infants receiving breastmilk plus complementary 
foods and/or milk-based liquids during the previous day 
 No breastfeeding: Proportion of infants not receiving any breastmilk during the 
previous day 
ii. Child 1–5 months old 
 As above (for children <1 month) 
iii. Children 6 to <12 months 
 Continued breastfeeding (exclusive, predominant or partial): Proportion of infants 
receiving breastmilk during the previous day 
 No breastfeeding 
iv. Children 12 months to <24 months  
 As above (for children 6 to <12 months) 
This part of the pathway is described in the [probability of breastfeeding outcomes] section 
(see section 4.3.1). Finally, based on breastfeeding practices, children may have different mortality 
rates by the age of five years. This part of the pathway is described in the [probability of 
mortality outcome] section (see section 4.3.1). 
Scenario 2: WINNN IYCF interventions not implemented  
As before, in this scenario, mothers may or may not be exposed to IYCF counselling, and 
subsequently have different levels of breastfeeding practices. This is because IYCF counselling is 
also offered at routine primary care in non-WINNN-supported LGAs. The ‘WINNN IYCF 
interventions not implemented’ scenario has similar pathways as the ‘WINNN IYCF interventions 
implemented’ scenario but with different rates of exposure to the intervention and different 
breastfeeding rates. 
4.3 Data sources for the decision model 
This section will present the data sources and assumptions used in the decision model. These 
data (also called model parameters in this context) include the probabilities of each pathway in the 
decision model and the associated costs and outcomes. Table 15 summarises the data sources for 
all model parameters; these are then described in detail in the text. 
Table 15:  Data sources for model parameters used in the economic analysis 
Model parameters Data sources 
Probabilities used in the decision model 
Probability of exposure to the IYCF 
interventions 
ORIE baseline and endline survey 
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Child breastfeeding practices  ORIE baseline and endline survey 
Probability of under-five mortality The LiST (based on breastfeeding rates) 
Costs used in the decision model 
WINNN programme costs 
WINNN programme expenditure data for Year 1 to Year 5, broken 
down by states, outputs and cost categories  
State and LGA-level programme costs 
ORIE-conducted interviews with SNOs, LNOs and WINNN LTAs in 
Jigawa, Katsina, Kebbi and Zamfara 
Health facility-level costs 
Various data sources were used for the calculations of these costs: 
ORIE-conducted interviews with SNOs, LNOs, and LTAs, WHO 
estimates, and ORIE HFS 
CV costs 
Various data sources were used for the calculations of these costs: 
WINNN CV motivation study, ORIE HFS, and WINNN monitoring 
service data  
4.3.1 Probabilities in the decision model 
4.3.1.1 Probability of exposure to the IYCF interventions 
WINNN supports the delivery of IYCF interventions through facility-based IYCF (f-IYCF) and 
community-based IYCF (c-IYCF) counselling.  
 f-IYCF counselling is provided at routine primary health care (PHC) services such as antenatal 
care (ANC) and CMAM facilities – as well as at health events such as Maternal, Newborn and 
Child Health Week (MNCHW) events. f-IYCF counselling is designed to be provided by trained 
health workers, although in practice CVs also support f-IYCF counselling in many facilities due 
to inadequate human resources for health (Qualitative Evaluation of the WINNN Programme – 
summary report, 2017). f-IYCF counselling includes counselling to groups of mothers and also 
one-to-one counselling.  
 c-IYCF counselling is provided by trained female and male CVs. Female CVs facilitate 
‘mother’s support groups’, and provide one-to-one counselling. Male CVs reach out to fathers, 
local and religious leaders, while both male and female CVs provide broader IYCF sensitisation 
in communities. WINNN supported the significant expansion of c-IYCF counselling to additional 
wards, from August 2015 to February 2016.  
Estimates on exposure to f-IYCF or c-IYCF counselling were derived from the ORIE quantitative 
endline survey (Quantitative Impact Evaluation of the WINNN Programme – Volume 1, 2017). The 
baseline and endline surveys asked mothers of children aged 0–35 months whether they received 
IYCF counselling in the community generally and whether they had received IYCF counselling at 
health facilities at specific ANC and post-natal care (PNC) sessions for their children. These 
exposure indicators were estimated in WINNN and non-WINNN areas at baseline and endline. 
The overall estimate of the IYCF interventions exposure at either community or facility at endline 
was 58.3% (95% confidence interval = 54.2% to 62.4%) in WINNN LGAs and 36.1% (95% 
confidence interval = 32.7% to 39.6%) in non-WINNN LGAs. Baseline and endline estimates of 
exposure to the IYCF interventions are presented in Table 16.  
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Table 16:  Probability of exposure to the IYCF interventions at baseline and endline in 
WINNN and non-WINNN areas (p1) 
Exposure Baseline Endline 
 WINNN areas 
Non-WINNN 
areas 
WINNN areas 
Non-WINNN 
areas 
f-IYCF counselling only  14.6% 14.3% 27.0% 28.7% 
c-IYCF counselling only 2.3% 1.7% 11.8% 3.2% 
f-IYCF counselling as well as 
c-IYCF counselling 
5.2% 2.6% 19.7% 4.2% 
f-IYCF or c-IYCF counselling 
(sum of the above) 
22.1% 18.6% 58.3% 36.1% 
4.3.1.2 Probability of breastfeeding outcomes 
Child breastfeeding practices are estimated in WINNN and non-WINNN LGAs at baseline and 
endline for children in the following three age groups: <1 month, 1 month to <6 months, and 6 
months to <24 months. The sources for this are the ORIE quantitative baseline and endline 
surveys, which asked about breastfeeding practices and dietary recall in the last day. With that 
information, we estimated whether the child is currently breastfed and the level of breastfeeding, 
i.e. exclusive, predominant or partial breastfeeding for children up to 6 months of age, and 
continued or no breastfeeding between 6 months and <24 months. Table 17 presents the 
breastfeeding rates at baseline and endline in WINNN and non-WINNN LGAs.  
Table 17:  Breastfeeding practices (by age) at baseline and endline in WINNN and non-
WINNN LGAs 
Age groups Baseline Endline 
 WINNN LGAs 
Non-WINNN 
LGAs 
WINNN LGAs 
Non-WINNN 
LGAs 
Children 0–<1 months     
Exclusively breastfed (p2) 13.4% 5.3% 29.2% 7.0% 
Predominantly breastfed (p3) 67.8% 80.5% 64.1% 76.7% 
Partially breastfed (p4) 9.9% 10.0% 6.1% 8.8% 
Not breastfed (p5) 8.9% 4.3% 0.7% 7.5% 
Children 1–5 months     
Exclusively breastfed 8.5% 2.7% 17.6% 7.2% 
Predominantly breastfed 70.2% 76.6% 64.5% 75.5% 
Partially breastfed 20.0% 20.1% 17.8% 17.3% 
Not breastfed 1.4% 0.5% 0.1% 0.0% 
Children 6–11 months     
Breastfed (p6) 98.8% 97.2% 99.5% 100% 
Not breastfed (p7) 1.2% 2.8% 0.5% 0.0% 
Children 12–23 months     
Breastfed 68.1% 71.7% 73.7% 76.9% 
Not breastfed 31.9% 28.3% 26.3% 23.1% 
4.3.1.3 Probability of mortality outcome 
The evidence suggests that breastfeeding behaviour is strongly related to the risk of diarrhoea and 
pneumonia in children and the subsequent mortality (Lamberti et al., 2011; Horta et al., 2013; 
Walker et al., 2013; Lamberti et al., 2013). Since our data did not include longer-term follow-up, it 
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was not possible to estimate under-five mortality directly from the primary data on breastfeeding 
rates. However, we used the well-established LiST, which was initially developed as part of Child 
Survival Series published in The Lancet in 2003 (Walker et al., 2013; Jones et al., 2003). The 
model has since been extended by the Child Health and Epidemiology Reference Group to handle 
further interventions and to handle populations and cohorts. 
The LiST 
The LiST software is freely accessible as part of the publicly available software package Spectrum. 
Its model is a linear, deterministic mathematical model. It includes breastfeeding as a critical tool 
for the prevention of diarrhoea morbidity and mortality, quantifying the increased risk of suboptimal 
feeding from 0 to 5 months, 6 to 11 months and 12 to 23 months of age.  
It inputs into the model breastfeeding rates as presented in Table 17, and then produces mortality 
per 1,000 live births as the output. Further details of the methodology can be found in Walker et al. 
(2013), Winfrey et al. (2011) and Steinglass et al. (2010). 
In the case of the IYCF interventions, the following process was followed: 
a. Inputs: breastfeeding rates (i.e. age-appropriate rates of exclusive, predominant and 
partial breastfeeding) in WINNN and non-WINNN areas were used as inputs (see Table 
17). These rates were provided for baseline and endline time points. 
b. Calculations: the model then used evidence on the relationship between IYCF practices 
and under-five mortality outcomes to calculate the under-five mortality rate in WINNN and 
non-WINNN areas based on the level of breastfeeding practices. 
c. Outputs: the model finally produces estimates of under-five mortality per 1,000 live births 
in WINNN and non-WINNN areas at the baseline and endline time points. Subsequently, 
we calculated the following DID estimate: 
DID (mortality)
= (difference in mortality between WINNN and non − WINNN areas at endline)
− (difference in mortality between WINNN and non − WINNN areas at baseline) 
This DID estimate for mortality was used as the outcome in the CEA. 
4.3.2 Costs in the IYCF interventions model 
Costs per mother reached were estimated for the various IYCF interventions cost centres before 
bringing them together into an overall cost per mother reached estimate. We estimate costs using 
the health services and societal perspectives to provide a better understanding of the budgetary 
costs of the programme. There are three levels at which costs are incurred in the provision of the 
IYCF interventions:  
1. Health facility costs: These are all costs that are directly incurred in delivering an 
intervention to an individual in the health facility (e.g. counselling mothers at ANC, PNC 
services, CMAM days and health events such as MNCHW events). These are sometimes 
referred to as treatment costs. Such costs comprise: i) health worker inputs—the time spent 
by different cadres of health workers on delivering the intervention; and ii) a proportion of 
overhead costs attributable to the IYCF interventions delivered within the health facility. 
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2. Community5: These are costs incurred by CVs, who are recruited, trained and supervised 
by WINNN to establish and facilitate ‘mother’s support groups’ as well as broader IYCF 
promotion in the communities. CVs receive stipends to cover training and meetings but are 
not generally remunerated for their time. The support group approach is intended to allow 
for peer support among pregnant women and mothers of children under two.  
3. Higher-level programme: These are costs incurred at a ‘higher level’ than the health 
facility or patient; that is, money that funds activities at the national, state and LGA levels 
that enable the effective implementation of the IYCF interventions. Two broad groups incur 
these costs: i) the WINNN programme; and ii) state and LGA governments. Broad 
categories of activities include training, social mobilisation, monitoring and evaluation, and 
planning and coordination. 
Table 18:  The IYCF interventions costs per mother reached by type of service and cost 
centre 
  f-IYCF component c-IYCF component 
Cost centre GBP1/ USD % GBP1/ USD % 
Higher-level costs (c1) 8.7 13.6 87% 9.9 15.4 80% 
WINNN programme 8.7 13.6 87% 8.7 13.6 70% 
State and LGA - - - 1.2 1.9 10% 
Health facility-level costs (c2) 1.3 2.0 13% - - - 
Health worker time 0.8 1.3 8% - - - 
Facility overheads 0.5 0.8 5% - - - 
CV costs (c3) - - - 2.5 3.8 20% 
Total: Health services 
perspective 
10.0 15.6 100% 9.9 15.4 80% 
Total: Societal perspective 10.0 15.6 100% 12.3 19.2 100% 
1/ Using an exchange rate of 1.56, calculated as the average of representative rates for the period September 
2011 to August 2016 (Source: IMF) 
In the CEA, cost per mother reached was multiplied by the level of exposure to the IYCF 
interventions in WINNN and non-WINNN areas (i.e. the data presented in Table 16). For instance, 
at the endline time point, 27% of mothers in WINNN areas were exposed to only f-IYCF 
counselling, 11.8% were exposed to only c-IYCF counselling and 19.7% were exposed to both 
facility-based and community-based IYCF counselling. Hence, the total cost of the IYCF 
interventions at the endline in WINNN areas was calculated as follows: 
WINNN IYCF interventions cost = (f-IYCF counselling cost x 27%) + (c-IYCF counselling cost x 
11.8%) + ([f-IYCF counselling cost + c-IYCF counselling cost] x 19.7%) 
Here, f-IYCF and c-IYCF counselling costs represent facility-based and community-based IYCF 
counselling costs per mother reached, respectively. Since cost data for the IYCF interventions 
were only available for WINNN areas through the ORIE evaluation, we assumed that the cost per 
                                               
5 Mothers or caregivers receiving IYCF-related services also incur costs in accessing IYCF-related services in terms of 
time and expenses. However, these costs are very difficult to collect and estimate, given that IYCF-related services are 
integrated into other services such as treatment at CMAM facilities, MNCHW events and other routine PHC services 
such as ANC or PNC. The time mothers spend on a CMAM day, including IYCF counselling, is already costed as part of 
the CMAM programme costing. Thus, the only costs for caregivers that are excluded from our analysis are those related 
to the time and expenses spent on c-IYCF and f-IYCF counselling at ANC or other facility services such as PNC or 
MNCHW events. However, it should be noted that we expect this cost to be marginal given the time IYCF-related 
services take in reality. 
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mother reached is the same in both WINNN and non-WINNN areas (although the probability of 
reaching mothers was different in WINNN and non-WINNN areas). 
Following the DID approach (as above), we calculated the DID in cost using the following formula: 
DID (cost) = (difference in cost between WINNN and non − WINNN areas at endline)
− (difference in cost between WINNN and non − WINNN areas at baseline) 
In the sub-section below, we will present the methods used to calculate cost per mother reached in 
health facility or community. 
4.4 Results of the IYCF interventions CEA 
The primary results of the CEA are presented below. Table 19 presents estimates of the IYCF 
interventions costs and mortality outcomes for WINNN and non-WINNN LGAs from the societal 
and health services perspectives. When using the societal perspective, the cost per mother (i.e. 
cost per mother reached x probability of exposure to the IYCF interventions) at baseline was £2.90 
and £2.22 for WINNN and non-WINNN areas respectively. Hence, the difference in costs at 
baseline was £0.69 per mother. At endline, this difference was £4.35. As a result, from a societal 
perspective, the DID estimate was £3.66 per mother (see  
Table 20). When using a health services perspective, the DID estimate for cost was £3.15 per 
mother. Next, we predicted mortality at baseline and endline for WINNN and non-WINNN LGAs 
using the child breastfeeding rates in the LiST. The tool anchored the baseline under-five mortality 
per 1,000 live births at 116.61 (based on the mortality estimates for Nigeria). It then predicted 
mortality using breastfeeding rates at endline, which were 108.64 in WINNN areas and 113.83 in 
non-WINNN areas. The DID estimate of mortality per 1,000 live births was 5.19 (or 0.00519 per 
live birth) between WINNN and non-WINNN LGAs (see  
Table 20). 
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Table 19:  Costs and mortality at baseline and endline in WINNN and non-WINNN areas 
 Baseline Endline 
Costs WINNN areas 
Non-WINNN 
areas 
WINNN areas 
Non-WINNN 
areas 
Societal perspective 
IYCF interventions cost per 
mother* 
£2.90 £2.22 £8.54 £4.19 
Difference between WINNN and 
non-WINNN areas in costs per 
mother 
£0.69 £4.35 
Health services perspective 
IYCF interventions cost per 
mother* 
£2.72 £2.11 £7.77 £4.02 
Difference between WINNN and 
non-WINNN areas in costs per 
mother 
£0.61 £3.75 
 Baseline Endline 
Mortality WINNN areas 
Non-WINNN 
areas 
WINNN areas 
Non-WINNN 
areas 
Predicted mortality per 1,000 live 
birthsǂ 
116.61 116.61 108.64 113.83 
* IYCF interventions cost per mother = IYCF interventions cost per mother reached x probability of exposure. 
ǂ In the LiST, the baseline mortality in WINNN and non-WINNN areas is anchored at the observed mortality per 1,000 
live births in Nigeria in 2013. Then, mortality at endline is predicted based on the change in breastfeeding rates from 
baseline. 
Calculations were made in USD and then converted to GBP using an exchange rate of 1.56, calculated as the average 
of representative rates for the period September 2011 to August 2016 (Source: IMF). 
Finally, we calculated the ICER using DID estimates of costs and mortality outcomes. Our estimate 
shows that the incremental cost per death averted is £706 ($1,102) from a societal perspective and 
£607 ($947.9) from a health services perspective ( 
Table 20).  
The LiST allowed for the estimation of long-term mortality for the IYCF interventions but did not 
allow any estimation of DALYs averted. This could be related to the preventative nature of the 
IYCF interventions, which can affect various long-term conditions – each of them with a different 
disability weight. In the case of CMAM, which is a curative intervention, the estimation of DALYs 
was more straightforward given that a single condition (SAM) is linked to a known disability weight. 
In this report, for comparison purposes, we assume 37 DALYs lost per premature death (as in the 
case of CMAM) to convert per life saved to per DALY averted. We estimate that the incremental 
cost per DALY averted for the WINNN IYCF interventions is £19.1 ($29.8) from a societal 
perspective and £16.4 ($25.6) from a health services perspective. The DALY estimate assumes 
that long-term mortality and disability in children who were alive at the age of five in the IYCF 
interventions model is similar to the children who were alive in the CMAM model after recovering 
from an episode of malnutrition. This is a conservative estimate (i.e. DALYs experienced by 
children who were alive in the IYCF interventions model may be under-estimated) given that we 
expect children with a history of SAM to have a higher long-term probability of disability/mortality 
compared to other conditions affected by suboptimal breastfeeding. 
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Table 20:  DID estimates and ICERs of the IYCF interventions (societal and health 
services perspectives) 
Incremental analysis 
Societal 
perspective 
Health services 
perspective 
DID estimate of costs between WINNN and non-WINNN 
areas* £3.66 £3.15 
DID estimate of deaths averted per live birth between 
WINNN and non-WINNN areasƗ 
0.00519 0.00519 
ICER for cost per life savedǂ £705.78 
($1,102.0) 
£607.09 
($947.9) 
ICER for cost per DALY averted¶ £19.09 
($29.8) 
£16.40 
($25.6) 
* DID estimate of costs is £3.66 = £4.35 minus £0.69 (from the previous table). 
Ɨ DID estimate of deaths averted by live birth is based on the previous table and is calculated as follows: (difference)endline 
– (difference)baseline = 5.19 – 0 = 5.19 per 1,000 live births = 0.00519 per live birth.  
ǂ The ICER is calculated as a ratio of the DID estimate of cost and DID estimate of deaths averted per live birth. 
¶ Following the CMAM analysis, we assumed 37 DALYs lost for every premature death. 
Calculations were made in USD and then converted to GBP using an exchange rate of 1.56, calculated as the average 
of representative rates for the period September 2011 to August 2016 (Source: IMF). 
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5 Discussion 
 This study aimed to evaluate the cost-effectiveness of the CMAM and IYCF interventions in 
northern Nigeria. The analysis was conducted from the societal and health services 
perspectives using a lifetime horizon. A decision modelling approach was used to estimate the 
difference in costs and health outcomes due to the WINNN programme. Based on our analysis, 
both the CMAM and IYCF interventions were found to be cost-effective and compare well with 
estimates in recent studies of CMAM programmes in northern Nigeria and in other countries. 
 For the CMAM programme, the ICER from a societal perspective was £30.8 ($48.0) for cost 
per DALY averted and £1,138 ($1,778) for cost per life saved. From a health services 
perspective, the ICER for the CMAM programme for cost per DALY averted was £27.8 ($43.4) 
and for cost per life saved was £1,028 ($1,606). 
 For the IYCF interventions, the ICER from a societal perspective was £19.1 ($29.8) for cost per 
DALY averted and £706 ($1,102) for cost per life saved. From a health services perspective, 
the ICER for the CMAM programme for cost per DALY averted was £16.4 ($25.6) and for cost 
per life saved was £607 ($947.9). 
 For the purpose of decision-making, the ICER values can be compared against the 
recommended cost-effectiveness threshold. A commonly used threshold is based on the WHO-
CHOICE model, which suggests that if the ICER per DALY averted is below the value of GDP 
per capita then the intervention is ‘very cost-effective’ while if it is between one and three times 
the GDP per capita then the intervention is ‘cost-effective’ (Hutubessy et al., 2003; Shillcutt et 
al., 2009). As a result, any intervention with ICER per DALY averted of over three times the 
GDP per capita is considered not cost-effective. The GDP per capita of Nigeria in 2015 was 
$2,617 according to the World Bank (World Bank, 2017); hence, the ICER per DALY averted is 
‘very cost-effective’ in all analyses. An alternative recommendation is to use the WHO regional 
GDP per capita value, which is $1,695 for the WHO region of ‘Afro D’6 (WHO, 2017). 
Regardless, the CMAM programme is still ‘very cost-effective’ based on this regional cost-
effectiveness threshold.  
 A recent development in the literature is the cost-effectiveness threshold based on opportunity 
cost. This country-level threshold was proposed by Woods et al. (2016) – the authors 
combined the GDP per capita and the value of a statistical life to propose a threshold to reflect 
the health opportunity cost. Based on this study, the threshold range for Nigeria is $239 to 
$1,545. Hence, an intervention that costs more than the higher estimate of $1,545 per DALY 
averted is considered not cost-effective. Based on this alternative threshold, the CMAM 
intervention is still considered to be cost-effective. Based on both thresholds, we can conclude 
that investing in the CMAM intervention provides a good return on health sector investment. 
 For decision-makers, it is also important to compare cost per DALY averted estimates with 
other health care interventions that are competing for the health care budget. We found that the 
WINNN CMAM and IYCF interventions have a much lower cost per DALY averted compared to 
many other preventative and curative interventions. For example, the cost per DALY averted is 
$117 for family planning programmes, $922 for antiviral therapy (DIFD, 2011)and $94 for an  
integrated prevention campaign focused on diarrhoea, malaria and HIV (Marseille et al., 2014). 
 When comparing the results of economic evaluations, it is of course important to acknowledge 
that estimates of cost-effectiveness inevitably differ between studies. This is for several 
reasons, which include differences in: the data sources used to collect cost data; sampling 
strategies; population groups; cost of goods and services in the evaluation area (including 
differences in staff salaries, overheads and transportation costs, both between and within 
                                               
6 Nigeria is in the ‘Afro D’ region based on WHO classification 
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countries); assumptions about costs, probabilities and outcomes in the analysis; and the 
perspective of the economic evaluation. 
Cost-effectiveness of the WINNN-supported CMAM programme 
 The results of our CEA of the CMAM programme in northern Nigeria are comparable to the 
estimates in recent studies of CMAM. For instance, Wilford et al. (2012) used a health services 
perspective and estimated that the ICER for CMAM in Malawi was $42 per DALY and $1,365 
per life saved. Similarly, Bachmann (2009) conducted a CEA of CMAM in Zambia using a 
health services perspective and found that the ICER for CMAM was $53 per DALY averted and 
$1,760 per life saved. In another study, Puett et al. (2013) evaluated CMAM in southern 
Bangladesh from a societal perspective and found that the ICER for CMAM was $29 per DALY 
averted and $1,344 per life saved. The reason for the lower estimates from Puett et al. (2013) 
is that the CMAM model was assumed to be implemented only by community workers (hence, 
outpatient staff and overhead costs were not included).  
 Another important study was conducted by Frankel et al. (2015) in Nigeria and estimated that 
the CMAM programme costs $30 per DALY averted and $1,117 per death averted. The 
difference in estimates between our study and Frankel et al’s (2015) is small and can be 
explained by a number of reasons. For instance, the cost estimate of CMAM per child in 
Frankel et al. (2015) was $123 compared to $131 (£84) in our study. The lower cost might be 
explained by the different methodology used. Also, Frankel et al. (2015) used different 
assumptions about treatment outcomes compared to our study. For instance, based on primary 
data collected in our study, the difference in mortality between untreated SAM and those 
children who recovered in OTP was estimated to be 13.5%; however, Frankel et al. (2015) 
assumed that this mortality difference is 15.7%, which makes CMAM more cost-effective. 
Similarly, mortality reduction in children admitted to SC was 8.7% (based on primary data) 
compared to 9.6% in Frankel et al. (2015). Also, Frankel et al. (2015) assumed higher mortality 
of untreated SAM (21.4%) compared to our estimated mortality of 20.2%, which is comparable 
to the 20.7% seen in Puett et al. (2013) and 20.8% in Bachmann (2009). 
 Another important point to note is that it appears that Frankel et al. (2015) did not take account 
of the coverage of the CMAM programme – instead, they appear to directly compare children 
who enrolled in the CMAM programme with those who did not. As a result, the treatment 
benefit (in terms of mortality and DALYs averted) will clearly be large as all children in the 
CMAM programme implemented scenario were assumed to enrol in the programme – this 
approach overestimates the treatment effect as it does not account for the fact that only a 
proportion of SAM children will enrol in the CMAM programme. Hence, it is not surprising that 
the ICER estimate of Frankel et al. (2015) is lower than the one in our study. 
 Finally, Tekeste et al. (2012) evaluated community-based therapeutic care in Ethiopia from a 
societal perspective and found that the cost of the intervention was $135 per child treated – a 
similar finding to the estimate of $131 (£84) per child treated in the current study. However, 
Tekeste et al. (2012) did not report any ICERs. 
Cost-effectiveness of the WINNN-supported IYCF intervention 
 The results of our CEA of the IYCF interventions were compared with the wider literature (see 
Annex C for a summary of the relevant studies). Only two relevant studies were found: Chola et 
al’s (2011) was conducted in Uganda and Nkonki et al’s (2014) in South Africa. Both studies 
were conducted by the Promoting Infant Health and Nutrition in Sub-Saharan Africa: Exclusive 
Breastfeeding Group (PROMISE-EBF). The intervention involved offering support provided by 
peer-supporters who recruited pregnant women attending routine ANC, establishing their 
feeding practices and then supporting them in breastfeeding practices. 
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 Both studies conducted economic evaluations from the provider’s perspective and excluded 
any costs incurred by mothers. The costing of the project was done using budget and 
expenditure data from the PROMISE-EBF programme. However, while these studies report 
intermediate outcomes, such as number of visits or number of weeks of EBF, neither evaluate 
the long-term outcomes, either in terms of reduced mortality or morbidity. Thus, it was not 
possible to compare our findings with these studies because long-term health benefits were not 
calculated/reported. 
Limitations 
 The economic evaluation has several limitations. While our study collected a significantly large 
amount of primary data on costs and outcomes compared to most other published studies, it 
still relied on some modelling assumptions. For instance, the estimates of access to the CMAM 
programme based on the endline survey were quite different – and are not comparable due to 
methodological differences – to coverage estimates coming from SLEAC surveys. Thus, the 
cost-effectiveness estimated with the probabilities of access coming from the endline are 
slightly more conservative. Second, because it is unethical to leave SAM children untreated 
after they are identified, it was not possible to directly estimate mortality in untreated SAM 
cases. Hence, following the conventional literature, we estimated this mortality using MUAC 
score in children before they received treatment. Our estimates were very similar or more 
conservative compared to other published studies. Another limitation is in relation to the cost 
estimation. WINNN personnel costs and other shared costs in WINNN higher-level expenditure 
were allocated using an activity-based costing apportioning. Although a standard approach, 
this method will be less precise than directly coded costs (i.e. if WINNN staff kept timesheets 
by output). It is also difficult methodologically to draw the line between which WINNN support 
costs are necessary for the successful implementation of the current IYCF and CMAM 
interventions and which are more related to future implementation. In our costing, we include 
all these costs that can have implications in the overall costs.  
 Finally, the CEA was based on mean estimates of costs and outcomes and did not consider 
the uncertainty in these estimates, which can be done using a probabilistic sensitivity analysis. 
This would be a useful exercise for future research. 
 We note that the findings of the CEA are somewhat different from the overall impact evaluation. 
There can be several possible explanations for this. First, the CEA specifically evaluates the 
effect of an intervention on treatment pathways (in terms of mortality and disability) rather than 
estimating the population-level effect of the intervention. Moreover, the CEA evaluates the 
longer-term effect of the intervention in terms of long-term mortality or DALYs averted, 
something which is not considered in the ‘within-study’ impact evaluation. However, it is 
important to note that the findings of our CEA are completely consistent with all the studies in 
the literature, which find that CMAM and IYCF interventions are cost-effective. 
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6 Key lessons and recommendations 
The principle objective of this CEA was to assess the return on investment of the WINNN 
interventions, not to develop detailed operational recommendations. ORIE has produced a 
separate document – the ORIE Nigeria Integrated Report (2017) – which draws on evidence from 
across ORIE workstreams to fully draw out lessons learned and recommendations targeted toward 
specific stakeholder groups such as the Nigerian government, donors and IPs. The Integrated 
Report also draws on evidence from across ORIE workstreams to report on WINNN’s logframe 
indicators.  
However, several important lessons and recommendations emerge from our CEA and are outlined 
below. In addition to DFID, the WINNN programme and the Government of Nigeria, these will 
hopefully prove useful to any professionals involved in the design of nutrition-specific and nutrition-
sensitive programmes in Nigeria.  
Lessons 
1) The economic analysis of the WINNN programme has demonstrated that nutrition-
specific interventions in Northern Nigeria can be cost-effective.  
2) While both interventions were found to be cost-effective, we learnt that high-level 
programme delivery costs, including those incurred by the WINNN programme, make 
up a significant proportion of the total programme cost (see ORIE Costing report 
(2017) for detailed analysis of the programme costs). Funding bodies should work with 
local governments to assess ways of reducing these costs while building local 
capacity and transferring programme ownership to state governments to scale up 
these interventions to the population level.  
3) This study has important lessons for future CEAs. ORIE engaged the implementers 
early in the programme, which allowed for the development of survey tools that were 
tailored to the evaluation to provide robust data (see Quantitative Impact Evaluation of 
the WINNN Programme – Volume 1, 2017 for details on the effectiveness data). This 
also allowed investigators to pilot test and improve the data collection methods for 
within-programme and follow-up data. As a result, compared to other economic 
studies of nutrition-specific interventions, this evaluation had to make fewer 
assumptions for the CEA.  
4) However, the cost-effectiveness estimates were constrained by the lack of data on 
health outcomes and particularly long-term ones such as children mortality. This 
should be planned for in future studies. This study also identified gaps in data in non-
intervention areas, such as the type and quantity of care received by children and their 
outcomes of care – this was overcome by making informed conservative assumptions 
based on the literature.  
5) Cost-effectiveness estimates were also constrained by the lack of long-term data on 
costs, which should equally be planned for in future studies. Data issues were also 
encountered in relation to programme-specific costs at state government level, with 
data both challenging to obtain and having significant variations in estimates and 
quality. These issues can be overcome through structured and coordinated efforts 
between funding bodies and state governments to develop and/or improve 
programme-specific budgetary reporting mechanisms. 
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6) Our study found that the cost-effectiveness estimates of nutrition-specific interventions 
varied based on the perspective of decision-making, and therefore it is important for 
future studies to plan data collection and present results from both the societal as well 
as health services perspective. 
Recommendations 
1) The cost-effectiveness evidence in this study found that both the CMAM programme 
and the IYCF interventions are cost-effective interventions for improving child health in 
northern Nigeria. This evidence is consistent with other studies conducted in Nigeria 
and other countries globally. This provides a basis to recommend that both 
programmes be considered by policy-makers and funding institutions as interventions 
that offer VfM in terms of improving child health outcomes. 
2) The coverage or exposure rate of the CMAM programme and the IYCF interventions is 
one of the determinants of cost-effectiveness. While both programmes were found to be 
cost-effective in this study, the coverage rates of both interventions remain low. The 
wider literature suggests that higher coverage level is likely to make the interventions 
even more cost-effective – this is because the fixed costs (such as high-level 
administrative expenditure) per child tends to reduce with increase in coverage due to 
economies of scale. Strategies to increase coverage should therefore be pursued by 
state governments in order to improve the cost-effectiveness of those interventions. 
Such strategies can include strengthening active case finding through a strong network 
of CVs, improving the access to IYCF-related services or improving the quality of 
service delivery.  
3) To further improve the cost-effectiveness of the CMAM programme, the programme 
should also aim to reduce default rates among enrolees, which will improve survival 
rates in children.  While this may require additional resources, the expected health 
gains in treatment completers will likely outweigh the additional costs. 
4) For the scale up of the CMAM programme and the IYCF interventions, resource 
implications must be considered carefully. This applies to both the resources required at 
higher-level as well as costs incurred at the level of health facilities and in the 
community. For instance, WINNN programme costs make up a large proportion of the 
cost of CMAM and IYCF interventions (i.e. 1/3rd of the total costs in case of the CMAM 
programme and at least 4/5th in case of the IYCF interventions). Therefore, the state 
governments should evaluate the budgetary capacity for scaling-up of these 
programmes. 
5) Given the challenges surrounding high-quality data in northern Nigeria, it is important to 
develop, at least at LGA level, a population-level monitoring and surveillance system on 
the nutritional status of children, their access to services, short-term treatment 
outcomes (such as rate of recovery after care and rate of recurrent episodes of 
malnutrition) and long-term outcomes (including mortality and disability rates), so future 
evaluations can benefit from robust data.
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Annex A Inception report 
A.1 Volume I (excerpts) 
A.1.1 Economic evaluation 
A.1.1.1 Rationale and objectives of the economic evaluation workstream 
The World Bank estimates that malnutrition is costing poor countries up to 3% of their yearly GDP. 
Moreover, malnourished children are at risk of losing more than 10% of their lifetime earnings 
potential. In resource-constrained health systems, the prioritisation of resource allocation across 
competing interventions requires evidence not only on effectiveness but also on cost-effectiveness. 
Such analysis is vital to the efficient allocation of resources to maximise health gains.  
The objectives of the economic study include: 
a) To estimate the direct and indirect costs and health-related outcomes associated with 
implementation of CMAM and IYCF interventions in northern Nigeria (WINNN Outputs 1 
and 2); 
b) To evaluate the cost-effectiveness of CMAM and IYCF interventions compared to routine 
care; and 
c) To evaluate the direct provider-related costs associated with WINNN outputs 3 and 4. 
A.1.1.2 Approach and methods 
We propose to conduct separate economic evaluations of each WINNN programme output, 
primarily because the outputs have different objectives, target health conditions, health outcomes 
and population groups. A full economic evaluation of the CMAM programme will be based on the 
cost-utility approach. The cost-utility approach uses a generic outcome, in this case the DALY that 
allows comparison of cost-effectiveness across programmes. Primary studies will be conducted to 
evaluate programme effectiveness, service delivery costs, health service utilisation costs and 
household costs. Based on this, a decision tree model (or an alternative Markov model) will be 
developed to evaluate patient treatment pathways (from identification of malnutrition to treatment 
to health outcomes) using costs and outcomes in CMAM programme and non-CMAM programme 
care to estimate the incremental cost per DALY averted. 
The economic evaluation of the IYCF interventions will compare programme delivery costs and 
health services costs against health outcomes that are directly influenced by the IYCF 
interventions. Based on primary data from the impact evaluation survey in intervention and control 
areas, the CEA will estimate the cost per unit of effectiveness outcomes such as the proportion of 
infants aged 0–6 months who are EBF and the proportion of children aged 6–23 months receiving 
foods from four or more groups (and if feasible, cost per DALY averted). Programme-related costs 
will be obtained in a primary costing exercise. 
The economic evaluation of outputs 3 and 4 will be take the form of a programme-based cost 
analysis, as no direct outcome data will be collected/available for these outputs. These costing 
studies are important for understanding the budgetary and economic implications of the 
programmes for health services and the funder.  
A.1.1.3 Key deliverables 
CMAM programme and IYCF interventions:  
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 results of the primary data analysis for costs and outcomes of the CMAM programme;  
 a fully functional economic model and cost per DALY analysis; and 
 a detailed report outlining and explaining findings. 
Outputs 3 and 4:  
 analysis of programme-related costs; and 
 a detailed report outlining and explaining findings. 
A.1.1.4 Key activities by year 
 2012: Key decision-making on primary data collection and the approach to analyses. 
 2013: Planning and organisation of primary data collection activities for all four outputs (first 
half of 2013); data collection initiated during second half of the year. 
 2014: Primary data collection of economic data completed by the end of 2014; report on 
findings. Structure of the economic models completed in 2014. 
 2016: Data from the impact evaluation exercise will be available. Analysis of primary economic 
data for all outputs will be conducted. Economic models and cost analysis will be completed. 
Report writing and dissemination. 
A.2 Volume II (excerpts) 
A.2.1 ORIE economic evaluation 
A.2.1.1 Introduction 
Childhood malnutrition remains an important public health and development problem in low- and 
middle-income countries, especially in sub-Saharan Africa. The World Bank estimates that 
malnutrition is costing poor countries up to 3% of their yearly GDP. Moreover, malnourished 
children are at risk of losing more than 10% of their lifetime earnings potential (Bachmann, 
2009). This can have a devastating economic impact on households. Caulfield et al. (2004) 
conducted a pooled analysis using 10 studies to estimate that 53% of child mortality is attributable 
to being underweight. Causes of death in malnourished children ranged from 44.8% for deaths due 
to measles to 60.7% for deaths attributable to dehydration as a result of diarrhoea. 
Prevalence of malnutrition in Nigeria has been found to be consistently high in most national and 
international studies. The Nigeria demographic and health survey 2008 suggests that 26.7% of 
children under five are moderately or severely underweight; of these, 12.7% were found to be 
severely underweight. More important, compared to previous surveys, the prevalence of 
malnutrition has not improved (27.3% in 1999 and 27.2% in 2003). Therefore, tackling malnutrition 
is one of the public health priorities for Nigeria. 
DFID Nigeria is rolling out an ambitious £50 million, six-year programme to improve maternal, 
newborn and child nutrition which will reach 6.2 million under-fives in five states of northern 
Nigeria. The programme has five outputs that are listed below: 
 Output 1: treatment of SAM via the CMAM programme through integrated services in primary 
health facilities; 
 Output 2: community-based interventions to improve IYCF practices through EBF, weaning 
and complementary feeding; 
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 Output 3: the integration of micronutrient interventions and deworming into routine primary 
health services (Vitamin A supplementation for children, iron and folic acid for pregnant 
women); 
 Output 4: more effective government planning and coordination in nutrition and related sectors 
at the national and state levels, and a stronger health system, through the integration of 
direct nutrition interventions into routine health services funded by the government; 
 Output 5: improved knowledge of what works to tackle child undernutrition in northern Nigeria 
via ORIE, which will be conducted by independent researchers and evaluation experts (output 
5). 
The economic evaluation workstream will concentrate primarily on outputs 1 and 2 for full 
economic evaluation, i.e. the CMAM programme and IYCF interventions of the programme. 
However, we will also discuss the scope of conducting costing studies (not full economic 
evaluations) for workstreams 3 and 4, i.e. the institutional implementation cost of the integration of 
micronutrient interventions and deworming (workstream 3) and integration of direct nutrition 
interventions into routine health services (workstream 4). 
A.2.1.2 Economic evaluation of CMAM programme/IYCF interventions: rationale and 
approaches 
In resource-constrained health systems across the world, and in particular in developing countries, 
the prioritisation of healthcare resource allocation across competing interventions requires 
evidence not only on effectiveness but also on cost-effectiveness. The CEA involves evaluating the 
impact of interventions on both costs and health outcomes. Such analysis is vital to the efficient 
allocation of resources to maximise health gains. 
There are primarily three potential approaches to full economic evaluation that can be used for the 
evaluation of the CMAM programme and the IYCF interventions (we have ignored cost–benefit 
analysis and cost-minimisation analysis as they are not relevant to the context of evaluation of 
CMAM programme/IYCF interventions). These are CEA, cost-utility analysis and cost-
consequence analysis. The three approaches differ in terms of how the outcome is measured 
against the costs. All three approaches are described below and their usefulness in the context of 
the current study is discussed. 
A.2.1.3 Approaches to economic evaluation 
Cost-effectiveness approach 
In a CEA, the outcome is programme-specific, such as the reduction in blood pressure (Logan, 
1981), number of positive cases detected (Hull et al., 1981), change in asthma episode days 
(Sculpher et al., 1994) and gain in life years (Mark et al., 1995). In the particular case of the CMAM 
programme, such outcomes may be related to indicators of nutritional status such as 
anthropometric indicators based on body size and composition. In the case of IYCF interventions, 
the relevant indicators may be the proportion of infants aged 0–6 months who are EBF and/or 
proportion of children aged 6–23 months receiving foods from four or more food groups. The CEA 
will produce estimates of VfM in terms of cost per unit of outcome measure. 
CEA is an incremental analysis, i.e. it evaluates the difference in costs and difference in outcomes 
between the interventions being evaluated. The resulting ICER of the CMAM programme/IYCF 
interventions will reveal the optimal alternative (compared to the control intervention), which may 
be: i) same cost but more effective than the alternative; ii) less expensive and at least as effective 
as the alternative; or iii) more expensive while providing additional benefit that is worth the cost. 
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This last scenario is the most common likely outcome of CEA. The incremental cost per unit of 
outcome is then evaluated against the willingness to pay for gain in one unit of the outcome. 
CEA can be useful when the decision-maker is interested in comparing alternatives within a 
particular field, for instance the CMAM programme against other interventions targeting 
malnutrition. However, the government or international funding organisations (i.e. a decision-maker 
with a broad health sector mandate) with priorities across all health conditions need to use 
outcome measures that are directly comparable across several health conditions to evaluate the 
maximum VfM in terms of health gain. As a result, generic measures of health, such as DALYs or 
quality-adjusted life years (QALYs) are frequently employed.  
On the other hand, CEA’s outcome (such as reduced incidence of malnutrition) can be easier to 
understand and communicate, especially when the focus of health gain is restricted to malnutrition. 
Moreover, the CEA approach is also useful in situations when converting specific outcomes to 
generic outcomes is not straightforward. This is likely to be the case when evaluating interventions 
that aim to promote breastfeeding and weaning (such as the case in IYCF interventions). However, 
as we will discuss in the literature review section, only a limited number of economic studies have 
achieved this using modelling approaches. 
Cost-utility approach  
The cost-utility analysis is the most common method of economic evaluation in the literature. It 
uses a generic measure of health outcome that can be compared across programmes. The most 
commonly used outcome measure in the economic literature related to developing countries is the 
DALY. An alternative to DALYs is the QALY outcome, which values health outcomes based on 
public preferences. QALYs have been more commonly used in the literature related to developed 
countries, where country-specific value weights (or utility weights) are available for specific 
population groups. Both outcomes combine survival and health-related quality of life. We will 
discuss the DALY in detail below as it relates directly to the evaluation of CMAM programmes in 
the literature. 
The DALY is primarily a measure of disease burden and has been used frequently in economic 
evaluations. DALY incorporates an age-weighting function assigning different weights to life years 
lived at difference ages. The calculation of DALYs is relatively simple as constant disability is often 
assumed. The formula to calculate DALYs averted is (Cairncross et al., 2003): 
DALYs averted= no. of deaths averted * YLL + no. of cases of illness averted * YLD 
YLL = years of life lost due to premature mortality 
YLD = year of life spent with disability 
As discussed above, the advantage of using a generic measure like DALYs is that a decision-
maker with a broad health sector mandate can compare VfM across several health programmes. 
For instance, Wilford et al. (2012) compared the cost per DALY averted of the CMAM programme 
in Malawi against other interventions such as the iron fortification programme in Malawi, with a cost 
per DALY of $66–70/DALY compared to the treatment of SAM with A cost per DALY of $41/DALY. 
Such an analysis puts the value of the intervention into perspective and allows decision-makers to 
prioritise healthcare financing. 
It should be noted that the two terms ‘cost-effectiveness’ and ‘cost-utility’ are often used 
interchangeably in the literature. This is because cost-utility analysis can be understood as a 
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specific type of CEA where the outcome of interest is a generic measure. Cost-
consequence analysis 
While it is common practice in the health economics literature to take the cost-effectiveness or 
cost-utility approach based on short- or long-term outcomes (Briggs et al., 2006; Drummond et al., 
2005), these approaches rely on translating the process or intermediate outcomes into a common 
outcome denominator, such as DALYs or QALYs. However, for interventions that have a diverse 
range of short-term outcome measures, a cost-consequence analysis is also appropriate. This 
approach is defined as an analysis ‘in which costs and effects are calculated but not aggregated 
into quality-adjusted life-years or cost-effectiveness ratios’ (Russell et al., 1996). This method is 
used to display all the key costs and consequences associated with the intervention for the 
purpose of comparison; the consequences are expressed in the most appropriate natural units for 
each outcome measure. This approach is particularly relevant when a wide range of 
multidimensional process outcomes are of interest for a particular intervention (Godber, Robinson 
and Steiner, 1997). The information presented in this format is understandable and usable for non-
health economists (Mauskopf et al., 1998), and it also overcomes the need for complex economic 
modelling to estimate the long-term effects expressed in terms of a single common outcome. This 
approach has been used in many studies in recent years (e.g. Burger, 2010; Ritchie et al., 2005; 
Bergmo, 2009; Barnett et al., 2009). 
However, the primary limitation of this approach is that it does not produce cost-effectiveness 
estimates in terms of cost per unit of outcome. Moreover, there is no generic measure of outcome 
to allow comparison across several conditions. Hence, cost-consequence analysis has limited 
application to situations where a single index cannot be used or is not meaningful. 
Costing study 
A costing study evaluates the costs associated with the delivery of an intervention; hence, a 
costing study should consider all relevant costs, depending on the perspective of the cost analysis 
(perspective is discussed in detail later). A costing study is a form of partial economic evaluation 
because only the costs are examined without reference to outcomes. However, this does not imply 
that a costing study is unimportant, as such studies are crucial for examining the budgetary 
implications of health services (Drummond, 2005) and represent an important stage in our 
understanding of the economic consequences of the workstreams for the health services and the 
funding bodies. Moreover, a costing study represents an important intermediate stage for future 
CEAs. 
Costing studies may use either a top-down or bottom-up data registration approach, and may be 
prospective or retrospective in relation to time. Cost-related data for costing studies may be 
obtained from accounting systems, budgets (allocated or spent), billing histories, accounting and 
statistical reports and other information systems. 
A.2.1.4 Perspective of the economic evaluation 
The perspective of an evaluation is important to the decision-maker, in order to determine to whom 
the costs incur. This matters because an intervention might be cost-effective from one point of view 
(e.g. a societal one) but not from another (e.g. a health care provider view). Hence, stating the 
perspective adopted is therefore an essential task for researchers and is consistently 
recommended in guidelines for economic evaluations. The two commonly used perspectives in 
economic evaluations are the health services perspective and the societal perspective. The former 
evaluates only the costs incurred by health service providers and associated organisations directly 
or indirectly engaged in providing care, such as the IPs in the case of the CMAM programme and 
the YCF interventions. However, the societal perspective also includes costs incurred by health 
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service users (i.e. patients and carers) and other members of society who may be directly or 
indirectly affected by the intervention (or no intervention). 
In the case of developing countries, the perspective of an economic evaluation can be crucial. This 
is because the costs (direct and indirect) incurred by patients and their family members can be 
significant compared to the actual health-related costs incurred by the health care systems. For 
example, out-of-pocket payments for medication, food, transportation and informal payments can 
amount to significant sums. Moreover, the opportunity cost of visiting health facilities can be huge 
due to wage loss. If such matters are taken into account, these costs can potentially make up a 
significant amount of the total societal cost of interventions. 
There is no consensus on which perspective should be used in an economic evaluation. In 
developing countries, there are no guidelines for such evaluations. Some reimbursement agencies 
in more developed countries, such as England and Wales’ National Institute of Clinical Excellence, 
recommend that cost should be adapted from the National Health Service and Personal Social 
Services perspective. The National Health Service perspective determines the mix of interventions 
that would maximise health outcomes within the limited health care budget. 
The advantage of using the societal perspective in economic evaluation is that it provides an 
estimate of the value of the societal return of health services investments. However, estimating 
societal costs may be time-consuming and resource-intensive and is therefore not always included 
in economic analyses. Moreover, in some cases the decision-maker is not interested in the 
opportunity cost and out-of-pocket expenditures of the beneficiaries of health services.   
Below we present a summary of cost elements that are included or excluded based on the 
perspectives of economic evaluation. 
Table 21: Inclusion and exclusion of costs by perspectives  
Cost elements 
Perspectives 
Societal 
Public 
purchaser 
Private 
purchaser 
Provider 
Health service costs All 
Covered 
expenses 
Covered 
expenses 
Expenses of 
provided 
services 
Productivity costs Included Excluded Excluded None 
Informal carers Included Excluded Excluded Excluded 
Transportation All If any paid If any paid Excluded 
Other non-health service 
costs 
All If any paid If any paid Excluded 
Source: Luce (1996) 
A.2.1.5 Focused review of economic evaluations of nutrition interventions 
We undertook a focused literature review to identify previous economic evaluations in CMAM and 
IYCF programmes to review the evaluation approaches used in the economic analyses, outcomes 
evaluated, data sources used and types of costs considered. The literature search was targeted to 
assist with the current study and was not intended to be a systematic review.  
We identified three relevant studies that reported full economic evaluations of interventions aimed 
at reducing severe malnutrition in children. One of these studies was an evaluation of the CMAM 
programme in Malawi (Wilford et al., 2011). We did not find any economic studies that evaluated 
the cost-effectiveness/cost-utility of any IYCF programmes. However, we found a health 
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technology assessment report that evaluated the economic impact of interventions promoting 
breastfeeding. We will summarise all four studies below. Lessons drawn from these studies have 
been used directly to inform the design methodology proposed in this document. 
Wilford et al. (2011) 
Wilford et al. (2011) evaluated the cost effectiveness of a CMAM programme among children 
under five in Dowa district, Malawi. 
A decision tree model was used to evaluate the cost-effectiveness of CMAM integrated into 
existing health services compared with the status quo (existing health services without CMAM) in 
Dowa district. Hence, the first two branches of the decision tree represented areas where CMAM 
was implemented against non-programme areas. Each malnourished child may be treated by the 
CMAM programme or the alternative programme or may go untreated. Each scenario was further 
divided into additional decision nodes, i.e. children in the CMAM programme exit the OTP facility in 
one of four possible ways: cured, died, non-recovered, or referred to the inpatient therapeutic 
programme due to complications. A child is assumed to be non-recovered after missing two 
consecutive fortnightly visits. These nodes are further divided until a terminal node of alive or death 
is reached. The proportion of malnutrition cases assigned to each node and its respective mortality 
was based on the data collected from the Dowa CMAM programme. 
The study was based on a health services perspective. The outcome (effect) was based on the 
DALY, which was estimated using the decision tree model for each treatment pathway (scenario). 
The incremental cost and effect of the two scenarios was used to estimate the incremental cost per 
DALY averted. This decision tree is an extension to the original Bachmann (2009) study; however, 
this present study includes an option of non-CMAM care alongside CMAM and no treatment. 
The cost of the CMAM programme was broadly separated between capital cost (cars, motorbikes 
and computers, which amounted to 3% of the total cost of the programme) and recurrent cost 
(97% of the total cost). Recurrent cost included: RUTF (32%), administration (24%), direct staff 
(19%), transport (8%), others (surveys/reviews, HIV and AIDS mainstreaming, upgrading storage – 
5%), clinic staff (5%), training (2%), medical supplies (1%), and inpatient costs for OTP facility 
referrals (1%). All costs were converted into 2007 USD for the purpose of analysis. 
The cost-effectiveness results showed that the ICER of implementing CMAM integrated into 
existing health services was $42 per DALY averted (or $1,365 per life saved), which is well within 
the Gross National Income per capita threshold of $250 (World Bank, 2008).  
We identified a few limitations of the Wilford et al. (2011) study. First, the perspective was limited 
to health services. Hence, patient-related resource use (e.g. time taken off work, health-related 
expenses, etc.) was not considered in this study. Second, the capital costs did not include the cost 
of new building work, renovation of office premises and the depreciation cost of existing facilities. 
Moreover, the cost of inpatient stays appears to be very small in comparison to other cost 
elements (i.e. 1% of the total cost), which would need to be further investigated. Further limitations 
are identified in the paper itself. 
Bachmann (2009) 
Bachmann (2009) assessed the cost-effectiveness of community-based therapeutic care (CTC) 
against no treatment for children with SAM in Lusaka, Zambia. This study later served as a 
precursor for the Wilford et al. (2011) study. 
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The CEA was based on a decision tree model and the health services perspective was used for 
cost and effectiveness. Two scenarios were considered: CTC or no treatment. Children receiving 
CTC could have one of four possible outcomes: referred to hospital, defaulted, died, or recovered. 
For the no treatment group, mortality was based on children’s HIV status. This option was not 
considered for the CTC group because the HIV status was not known for most children and also 
some of the symptoms would already be incorporated into CTC outcomes. 
The probability for each option was used in the model to estimate the expected rate of outcome 
(i.e. recovery or death). Relevant costs were also added into the model with the exception of the 
no treatment option. Effectiveness was measured in terms of DALYs. Mortality rates were based 
on a community-based cohort study conducted in Malawi and Uganda.  
The relevant cost components used in the model included: health centre visits, RUTF, hospital 
admissions, community mobilisation, and technical support. All costs were converted to 2008 USD.  
The cost-effectiveness results showed that the cost of CTC was $1,760 per life saved and $53 per 
DALY gained. The cost-effectiveness acceptability curve showed that, at a willingness to pay of at 
least $88 per DALY gained, CTC was more than 80% likely to be cost-effective.  
Ashworth and Khanum (1997) 
Ashworth and Khanum (1997) assessed three alternative cost-effective approaches for treating 
severely malnourished children in Bangladesh. The study was based on a longitudinal, prospective 
controlled trial conducted to evaluate the most cost-effective treatment for severe malnutrition. In 
total, 573 children were sequentially allocated to three treatment groups. The three main treatment 
options evaluated were: inpatient management, day care, and domiciliary care.  
The cost component was categorised into institutional cost and parental cost. Institutional cost 
comprised capital cost, salary cost, utilities, laboratory tests, medical supplies and food costs. 
Parental cost comprised transport costs, wage loss of working mother and child food cost (day 
care). The cost-effectiveness was evaluated as the total cost (institutional and parental cost) to 
achieve 80% weight-for-height. All costs were reported in USD. 
The study showed that the institutional cost of inpatient treatment was 2.6 times more than for day 
care, and 5.3 times higher than domiciliary care. When combined institutional and parental costs 
were considered, domiciliary care was 1.6 times more cost-effective than day care and 4.1 times 
more cost-effective than inpatient care. 
This study is more comprehensive in terms of collection of cost data than the earlier studies. 
However, the study did not use a generic measure of effectiveness that can be compared across 
health programmes. 
Renfrew et al. (2009) 
The objective of this study was to estimate the long-term costs and benefits of enhanced staff 
contact in promoting breastfeeding to mothers whose infants were admitted to neonatal units. 
The rationale of the model structure was that enhanced staff contact increases milk expression; in 
turn, it was assumed that this would lead to increased milk consumption by the infant. Milk 
consumption was then assumed to reduce the incidence of illness episodes, thereby improving 
long-term health outcomes. The health benefits evaluated were in the form of QALYs. 
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Population:  All mothers with infants (<2500g) in neonatal units. Weight-based subgroups were 
developed with the rationale that the incidence of diseases increases greatly as the birth weight 
decreases: 500–999g, 1,000–1,749g, 1,750–2,500g. A health care perspective was used, and 
costs and benefits were discounted at the annual rate of 3.5%. 
Intervention:  In the base case model two interventions were evaluated: enhanced staff contact – 
the addition of specially trained staff, which would be available to advise and support mothers on 
milk expression and breastfeeding – compared with normal staff contact, i.e. no addition of 
specially trained staff. 
Model: The model divides the population into those women who intend to breastfeed and those 
who do not intend to breastfeed prior to their infant’s birth. The model was designed to capture the 
health effects for three different levels of milk consumption: all own mother’s milk, some mother’s 
milk (supplemented by formula in the base case) and formula alone. The literature suggests that 
there are potential cost and benefit differences in the different levels of mother’s milk consumption. 
Clinical outcomes: In hospital clinical outcomes were sepsis and mortality. Sepsis was further 
divided into Gram-negative, Gram-positive and fungal infection. Resource use and utility outcomes 
were captured by these subdivisions of clinical outcomes. 
Long-term outcomes: QALYs were used as a long-term outcome. The outcome was linked to 
disability by mean of neurodevelopment impairment, which is a composite measure that captures 
many elements of disability including visual, hearing and mobility impairments. The 
neurodevelopment impairment scores were divided into four categories: no, mild, moderate, and 
severe disability. The utility values for each of the health states were then used to quality weight 
life expectancy. Life expectancy for infants in each of the four disability states were taken from 
Colbourn et al. (2007). A combination of life expectancy and utilities were used to derive QALYs for 
each of the disability states.  
A.2.1.6 Aim of the economic evaluation 
The aim of this ORIE study is to evaluate the incremental cost-effectiveness (or cost-utility) of the 
CMAM programme (workstream 1) and the IYCF interventions (workstream 2) compared to routine 
care, and to evaluate the costs associated with delivery of the micronutrients and deworming 
programme (workstream 3) and integration of direct nutrition interventions into routine health 
services (workstream 4) in northern Nigeria. 
Specific objectives of the study include: 
a. To estimate the direct and indirect costs associated with implementation of the CMAM and 
IYCF interventions;  
b. To evaluate the health-related outcomes associated with the CMAM and IYCF interventions 
for the purpose of economic evaluation; 
c. To evaluate the cost-effectiveness of the CMAM and IYCF interventions compared to 
routine care in northern Nigeria; and 
d. To evaluate the direct provider-related costs associated with the implementation of 
workstreams 3 and 4. 
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A.2.1.7 Study methodology 
Overall approach of the economic evaluation of the CMAM programme and the IYCF 
interventions 
Separate workstream-specific evaluation or joint evaluation? 
For the purposes of an economic evaluation, it is important that the interventions being compared 
are targeted toward the same condition, such as severe malnutrition. Since the two programmes 
being evaluated in this study (i.e. CMAM programme and the IYCF interventions) have different 
objectives and different target health conditions, health outcomes and even population groups, we 
propose that, for the purposes of the economic evaluation, the CMAM and IYCF interventions are 
evaluated and reported on separately. Moreover, the two programmes work or can work 
independently of each other. For instance, the CMAM programme is operational in several 
countries as an independent programme in itself. The programme has been evaluated and 
published as such in the following four countries: Zambia, Ethiopia, Malawi and Bangladesh. We 
strongly believe that, besides the technical reasons outlined above, a separate economic 
evaluation to determine the VfM of each workstream can be crucial for decision-makers. 
However, we acknowledge that DFID as the funding institution may require that the two 
workstreams are evaluated together as one programme. Hence, although we do not recommend 
that the workstreams are evaluated jointly, one such potential joint approach is discussed later on. 
CMAM programme (Workstream 1) 
We propose to conduct a full economic evaluation of the CMAM programme based on a cost-utility 
approach (i.e. cost per DALY method) outlined above. Following Wilford et al. (2011) and 
Bachman et al. (2009), we propose that a decision tree model (or an alternative Markov model 
based on the same principles) is developed for the evaluation of the CMAM programme to 
evaluate the cost per DALY of the intervention compared to non-CMAM programme care. The 
decision model (discussed below) evaluates patient treatment pathways (from identification of 
malnutrition to treatment to health outcomes) based on the probability of different outcomes along 
the pathway for the alternative interventions being compared. Costs and health outcomes along 
the pathway are evaluated and aggregated. Health outcomes (i.e. malnutrition-related health state) 
are converted into DALYs (as discussed in the cost-utility section above). Costs and outcomes are 
subsequently evaluated together to estimate the incremental cost per DALY for the intervention 
(i.e. CMAM programme) compared to routine care. This approach is summarised in the figure 
below. The detailed decision tree approach will be discussed in the following sections. 
Figure 5: Proposed approach for the economic evaluation of the CMAM programme 
workstream 
 
 
 
 
Decision tree (or 
Markov) model: 
Patient identification and 
treatment pathway (using 
transition probabilities 
along the pathway) 
Costs and health outcomes 
associated with health states (such 
as malnutrition status) in the 
treatment pathway are recorded. 
Costs are aggregated and health 
outcomes are converted to DALYs. 
Cost per DALY 
analysis is 
conducted 
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IYCF interventions (Workstream 2) 
For our evaluation of the IYCF intervention, we propose two alternative options:  
 A model-based cost-utility analysis where the intermediate outcomes of breastfeeding (and 
possibly weaning and complementary feeding) can be converted into a generic utility-based 
measure of DALY or QALY as presented in the literature review above (see Health Technology 
Assessment report);  
 Cost-consequence analysis (discussed above);  
The cost-consequence analysis is relatively straightforward as it does not require the aggregation 
of multiple outcomes to generate a single outcome. However, for decision-makers intending to 
compare across programmes, such an approach may have limited application. The other 
alternative, i.e. the cost per DALY approach, is similar to the approach proposed for the CMAM 
programme; however, unlike malnutrition, it is not straightforward to derive disability-weighted 
outcome measures for breastfeeding, weaning and complementary feeding outcomes. 
Nevertheless, an indirect approach has been used in the literature. In this approach, indicators of 
feeding practices (such as whether or not a child is breastfed) are obtained from an impact 
evaluation; following this, estimates of the probability of the health-related consequences of 
undesired feeding practices (such as no EBF) are obtained from the literature for the specific 
population or the closest population group. Subsequently, the disability weights are attached to 
health-related consequences based on the estimates available in the literature – this allows us to 
calculate DALYs associated with the intervention. The same is done for the control areas to obtain 
DALY estimates. To estimate cost data, intervention-related costs for the providers are obtained 
using the institutional cost approach (discussed later). Furthermore, the health services costs and 
patient-related costs associated with treating health-related consequences (such as diarrhoea) are 
obtained. All the cost data are aggregated and compared against DALYs to obtain the cost per 
DALY. This approach has been used in several studies (including Renfrew et al. (2009) presented 
above) and is recommended for full economic evaluation. The approach is summarised in the 
figure below. 
 
 
 
 
 
 
 
 
Figure 2: Proposed approach for the economic evaluation of the CMAM programme workstream 
Combined analysis of CMAM and IYCF interventions 
While we recommend that the economic evaluation of the CMAM programme and the IYCF 
interventions workstreams are conducted and reported on separately (i.e. that the costs per DALY 
Impact evaluation: 
Indicators for feeding 
practices (such as 
exclusive, partial or no 
breastfeeding, or initiation 
of complementary feeding) 
Health outcomes: health-related 
consequences associated with 
undesired feeding practices are 
identified through literature review (such 
as diarrhoea/respiratory infections)  
health-related consequences are 
converted into DALYs Cost per 
DALY analysis 
is conducted 
Costs: a) Health provider costs 
associated with the delivery of IYCF; 
and b) health services and patient-level 
resource use associated with health 
consequences of undesired feeding 
practices (such as diarrhoea) 
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are estimated separately for the two programmes), the evaluation of the two workstreams can 
potentially be combined. This may only make sense if the resources used for the two workstreams 
have a significant degree of overlap, such as the use of community health workers. For a 
combined evaluation, the health benefits of the two programmes, expressed in terms of a common 
currency (i.e. DALYs averted), can be combined to estimate the combined effect in terms of 
DALYs averted; this outcome measure is then evaluated against the costs associated with 
implementing the two workstreams.  
However, in this case, it is crucial to avoid double counting costs and outcome benefits. 
Some of the health service resources may be common across the two workstreams, such as 
support/advice provided by community health workers or high-level supervision provided by senior 
management. It is important that such costs and any health benefits that may be common to the 
two workstreams are identified early on through discussions with programme delivery teams and 
that the evaluation process reflects these common costs and outcomes to avoid double counting. 
Micronutrient interventions and deworming (workstream 3) and integration of direct 
nutrition interventions into routine health services (workstream 4) 
While an outcome evaluation of workstreams 3 and 4 is not part of the impact evaluation exercise 
(as no outcome data will be available for them), these workstreams can/will be evaluated as part of 
the economic evaluation. We propose that the economic evaluation of workstreams 3 and 4 takes 
the form of a costing study or cost analysis. 
The costing study will take a health provider or institutional perspective. Further details are 
discussed in the following section. 
Table 22: Proposed approaches for the economic evaluation 
Programme Approaches for the economic evaluation 
CMAM intervention (Workstream 1) Cost-utility analysis (cost per DALY) 
 Options 
IYCF intervention (Workstream 2) Cost-utility analysis Cost-consequence analysis 
Micronutrients/deworming (Workstream 3) Costing study 
Integration of direct nutrition interventions 
into routine health services (Workstream 
4) 
Costing study 
A.2.1.8 Framework for the economic evaluation  
It is common practice in economic evaluations to use decision tree models or Markov models, 
especially in situations when the aim is to evaluate the long-term cost-effectiveness of 
interventions. The decision tree represents a sequence of events with different probabilities along 
the pathway with associated costs and health outcomes. The decision tree is then rolled back to 
estimate the expected costs and expected health benefits of interventions and comparators. These 
values can be averaged on the basis of the likelihood, or probability, of each path in the tree.  
CMAM programme model: the decision tree approach 
The decision tree approach was also used in the Wilford et al. (2011) study, which also evaluated 
the cost-effectiveness of a CMAM programme. Similarly, Bachmann (2009) also used the same 
approach. An alternative approach would be to develop a Markov model, which is a cohort model 
that is commonly used when the decision tree becomes too unwieldy with recurrent events or 
when time is an important consideration in the transition pathway. For relatively simpler cases, the 
decision tree approach is usually appropriate and sufficient; however, we suggest that the option to 
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use a Markov model should be considered if it becomes obvious that more states and/or decision 
nodes are required than can be comfortably handled by the decision tree. 
We propose that the economic analysis is based on a decision modelling approach that uses a 
decision tree or Markov model. The decision tree approach is close to the method used by Wilford 
et al. (2011). However, our interpretation of the Wilford model suggests that it has several 
limitations that can be improved upon in this study:  
 The Wilford et al. (2011) model is primarily a treatment-based model, i.e. it does not explicitly 
model community-based case findings; this is an important and integral part of the CMAM 
programme. We propose that the model in this study starts by introducing probability at the 
start of the decision tree to take into account the case finding of a malnourished child who is 
then referred to outpatient or inpatient therapeutic care. 
 The Wilford et al. (2011) model was based on a health services perspective but we propose 
that a societal perspective is taken to capture the full impact of the WINNN interventions on 
society. 
 The Wilford et al. (2011) study did not collect any data from control or non-CMAM programme 
sites, and made assumptions around programme effectiveness. This is a serious limitation that 
we propose addressing in the current study. 
 Wilford et al. (2011) assumed that the no treatment arm did not incur any costs. We think this 
assumption needs to be evaluated.  
 Wilford et al. (2011) used several other assumptions when data were not available. The validity 
of some of these assumptions may be contestable. We propose that robust data are collected 
so that fewer assumptions are made. 
 We do not see that the Wilford et al. (2011) model considered the cost of death, i.e. the high 
expenditure associated with healthcare before death. 
Thus, the Wilford et al. (2011) model should be revisited and further areas of improvement should 
be explored. However, we agree with the general approach of using a decision tree for this 
purpose, although as noted above the need for a Markov model should be revisited later on. We 
understand that there may be opportunities to contact the authors directly to better understand the 
model parameters and how our study can improve on them. 
For illustration purposes, we present a modified version of the decision tree presented by Wilford 
et al. (2011). It should be noted that the decision tree is likely to be modified at a later stage. The 
required model parameters will be discussed in the cost and outcomes sections. 
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Figure 6: Decision tree for the CEA of the CMAM programme 
 
Analysis of the IYCF interventions workstream 
As discussed earlier, the analysis of the IYCF intervention will take one of the two forms: a cost-
utility analysis or a cost-consequence analysis. We propose that the cost-utility analysis option 
should be explored first because it would allow decision-makers to compare the VfM of the IYCF 
intervention against other competing interventions. While the outcomes of IYCF interventions 
cannot be directly associated with disability or utility weights, we propose that the immediate 
outcomes from the impact evaluation (e.g. breastfeeding rate) are mapped onto the probability of 
longer-term benefits in terms of health-related consequences averted (such as diarrhoea, 
respiratory infections or possibly other infections), which are then used to estimate DALYs averted. 
We have presented one study in the literature review section (Renfrew et al., 2009) that conducted 
such an analysis for an intervention aimed at promoting breastfeeding.  
Analysis of workstreams 3 and 4: costing study 
Cost studies are usually conducted to provide budgetary estimates or to estimate the costs of a 
programme initiative. The costing study of workstreams 3 and 4 will be conducted from a provider’s 
perspective to capture all programme-related costs. These are discussed in detail later and will 
include programme investment costs and operational costs, including staff salaries, procurement 
and distribution of supplies (such as Vitamin A capsules for children and iron and folic acid for 
pregnant women), supervision costs, training costs and travel costs. 
A.2.1.9 Perspective of the economic evaluation 
As discussed above, it is important to establish the perspective of an economic evaluation. Both 
health services and societal perspectives have been used in economic evaluations of interventions 
targeting severe malnutrition (presented in the literature review section above). Wilford et al. 
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(2011) conducted a cost-per-DALY analysis of the CMAM programme using a health services 
perspective. No patient-related costs were included in the analysis. Similarly, Bachmann (2009) 
used the same approach and focused only on the health services perspective. However, Ashworth 
and Khanum (1997) used a societal perspective to include parent-related costs such as transport 
costs, wage loss for working parents, payments to neighbours for looking after the family in the 
mother’s absence and child’s food cost when at home. However, the costs of out-of-pocket 
expenditure on health services were not considered. 
We propose that, for the full economic evaluations of the CMAM programme and the IYCF 
interventions workstreams, the preferred option is to take a societal perspective. The potential cost 
elements to be included in Table 21 presented earlier are discussed in detail in the following 
section. There are several reasons for proposing a societal perspective for this analysis: 1) a 
societal perspective in an economic evaluation provides an estimate of the return of investment on 
health services for society; 2) the burden of malnutrition and the burden of care seeking have 
direct cost implications for households; and 3) a restricted budget perspective is inconsistent with 
decisions based on willingness to pay for DALYs. However, for pragmatic reasons we propose that 
due consideration should be given to both perspectives. In the following discussion on cost 
components, we will discuss all relevant costs, including societal costs. A decision can be reached 
later in terms of which perspective should be adopted. 
Costing studies generally tend to take a provider’s perspective. This is mainly because the aim of 
the costing study is to provide budgetary estimates or to estimate the costs of a programme 
initiative to the provider. A broad health services or societal perspective is more appropriate when 
a full economic evaluation is planned. For the current scenario, we propose that all costs 
associated with delivering workstreams 3 and 4 are captured during the evaluation using the 
provider’s perspective. 
In the following sections, we discuss the costs and outcomes to be included in the economic 
evaluation. We present specific cost components, line items, potential sources, method of data 
collection and process of cost estimation. We will also discuss a CMAM-specific costing tool that 
has been developed by Food and Nutrition Technical Assistance (FANTA). Following this, the next 
section will discuss the outcome measures required for the economic analysis and their potential 
sources, and will also identify the sources used by previous studies. 
A.2.1.10 Cost components of CMAM programme and the IYCF interventions 
Two broad categories of cost for economic evaluation 
The following cost elements will be collected for the evaluation of all four workstreams: 
1. Programme delivery costs (A): these include capital costs, fixed operating costs and 
variable operating costs, which are outlined in the table below. These cost elements relate 
to programme inputs for service delivery, monitoring, training, supervision, community visits 
to households and provision of curative care. These costs are discussed in detail in the 
following section.  
2. Household costs (B): these costs relate to household expenditures in relation to the 
health condition. As discussed above, the household costs will only be considered in the 
evaluation of workstreams 1 and 2 and will not be part of the costing study of workstreams 
3 and 4. 
For programme delivery costs of all workstreams, the CMAM cost template from USAID’s FANTA-
2 project (summarised later in the document) will be used. This document can be adapted to suit 
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workstreams 2–4 and will ensure that cost elements are captured in a standardised format across 
all workstreams. 
Programme delivery costs (A) 
Programme costs may be incurred by the IPs, i.e. UNICEF, Save the Children, and ACF, and the 
government health provider that provides care. Hence, during the process of evaluation, all 
programme-related costs should be evaluated for all organisations involved in the delivery, 
management, supervision or other directly related activities of the programme.  
The programme components of the CMAM intervention can be represented by the diagram below, 
which shows community outreach services, outpatient services, inpatient care and services and 
programmes addressing management of malnutrition. Based on this, the cost components can be 
identified and are listed below. 
Figure 7: Programme-related components of the CMAM intervention 
 
Source: UNICEF (2013)  
Activities that will incur costs in the CMAM programme: 
 Treatment (or case management) of children with SAM (on either an inpatient or an outpatient 
basis);  
 Community outreach in support of the management of SAM;  
 Supply logistics (transportation and storage of supplies, especially of RUTF and other 
therapeutic food);  
 Training of health care providers and health managers;  
 Supervision of health care providers and health managers; and  
 Management of the service/programme (e.g. planning, budgeting, monitoring).  
Activities that will incur costs in the IYCF interventions: 
Similarly, the cost components of the IYCF interventions are listed below: 
 Mothers’ support group training and other training; 
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 Information, education and communication materials; 
 Sensitisation and community outreach; 
 Training of health workers; 
 Supervision of health care providers and health managers; 
 Management of the service/programme (e.g. planning, budgeting, monitoring);  
 Festivals (e.g. breastfeeding weeks); and 
 Mass media. 
For the economic evaluation of the IYCF intervention, the last two cost elements may not be 
included in the analysis. 
Activities that will incur costs in workstreams 3 and 4: 
 Supply logistics (procurement, transportation and storage of supplies, especially Vitamin A 
capsules for children and iron and folic acid for pregnant women); 
 Distribution costs; 
 Training costs;  
 Supervision of health care providers and health managers; and 
 Management of the service/programme (e.g. planning, budgeting, monitoring).  
Household costs related to health conditions 
These costs are related to household out-of-pocket expenditure or opportunity costs associated 
with the health condition. For instance, for the evaluation of the CMAM programme, the household 
costs may include the following: 
 Out-of-pocket payments for medication; 
 Informal payments; 
 Expenses on transportation; 
 Expenses on food; 
 Employment status; 
 Daily wage; and 
 Payments to neighbours for looking after the family in the mother’s absence.  
Types of programme-related costs for all workstreams 
For practical purposes of cost analysis, we propose that the above cost components are evaluated 
in three categories: capital costs, fixed operating costs and variable operating costs. These are 
defined with specific examples from the CMAM/IYCF interventions in the table below. In the 
following section, we have identified specific cost line items for each one of these categories, and 
further details are provided. 
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Table 23:  Types of programme-related cost included in the economic evaluation of the 
CMAM/IYCF interventions 
Type of cost Description 
Programme-specific costs for CMAM 
programme and IYCF interventions 
Programme 
capital costs 
* These are direct costs that can be 
incurred at the start of a programme 
or at later stages.  
* These will include infrastructure-
related costs, equipment and vehicle 
purchase costs and training costs. 
* To avoid losing cost-related 
information, it is best practice to 
collect this cost data early on, and 
also at later time points. 
* Construction or start-up renovation/repair 
of facilities. 
* Depreciation of existing facilities. 
* Cars and other vehicles. 
* Computers and other office equipment. 
Fixed operating 
costs 
* These are fixed direct costs that are 
incurred regularly regardless of 
programme-related variable 
indicators. 
* These may include the salaries of 
staff members (full or part time), 
facility rents and utilities. 
* Salaries of full-time and part-time staff. 
* Rent of facilities/items. 
* Utilities and other bills. 
Variable operating 
costs 
* These are variable direct costs that 
increase with the volume of service, 
and may not have much impact on 
cost per capita 
* These may include medical 
supplies, training materials, 
maintenance costs, supplies and 
variable staff costs. 
* Ready-to-use food supplements. 
* Medication supplies. 
* Laboratory tests. 
* Vehicles (repairs and fuel). 
* Training costs (including training 
materials). 
Capital costs to be evaluated for the economic analysis of all workstreams 
Summaries of the cost data required, estimation methods, sources of data and assumptions are 
presented in the tables below. These include capital costs (i.e. costs related to starting up a 
nutritional programme at a health facility) and operating costs (i.e. the expenditure required to keep 
the facility fully functional). Operating costs are further divided into fixed operating costs, which 
include staff salaries, and variable operating costs, which include RUTF, medical supplies, 
laboratory test, utility bills, training costs and vehicle maintenance and fuel costs. 
These cost elements should be thought of as programme inputs to service delivery, monitoring, 
training, supervision, community visits to households and provision of curative care. All cost 
elements below should be collected with such activities in mind. 
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Table 24: Capital cost elements for CEA of CMAM/IYCF interventions  
Capital costs Who will incur the cost? Cost estimation 
Building facilities 
a. Cost of any new building facilities 
developed specifically for the programme (such as 
community-based treatment facilities). 
These costs are likely to be related to 
renovation/redecoration/construction of government 
health facilities.  
However, they may be incurred by the health service 
provider (i.e. the government) or IPs (i.e. Save the 
Children and ACF). 
Costs incurred at the central offices and local and 
community offices will be investigated.  
It is important to ensure that costs are not double 
counted when gathering data from multiple sources. 
Estimation of depreciation cost: Attributable 
depreciation cost of building facilities will be 
estimated based on proportionate service activity 
(i.e. number of patients seen or admissions) 
attributable to the CMAM/IYCF intervention. A 
lifespan of 30–50 years will be assumed, 
discounted at 3% and 5%, and uniform 
depreciation will be used in calculations.  
b. Start-up cost of renovating/restructuring 
existing building facilities used for CMAM/IYCF 
intervention (i.e. outpatient and inpatient treatment 
facilities). Also, depreciation cost of existing 
buildings used for CMAM/IYCF intervention will also 
be considered. 
Equipment and furniture 
a. Purchase of new equipment, such as 
laboratory machines, and furniture for the 
programme (including community-based care, 
outpatient and inpatient facilities). 
These costs can be related to purchases or use of 
existing equipment and furniture based at the offices of 
the IPs or health provider. Estimation of depreciation cost: Attributable 
depreciation cost of equipment will be estimated 
based on proportionate use attributable to the 
programme annualised to 10 years, discounted at 
3% and 5%. 
b. Estimated depreciation cost of existing 
equipment shared with other services (such as 
machines in outpatient and inpatient facilities). Also, 
initial cost of repairs will also be included. 
 
Vehicles 
a. Purchase of new cars, motorbikes and 
other means of transportation for the programme 
and start-up repair costs. 
These costs are likely to be related to IPs. 
Estimation of depreciation cost: For vehicles 
used only for the programme, depreciation costs 
will be calculated over the lifespan of the vehicle 
and attributed completely to the programme. For 
vehicles shared with other programmes, 
depreciation cost will be estimated by keeping a 
b. Depreciation cost of existing vehicles used 
for the programme. 
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log of total kilometres driven for CMAM/IYCF 
intervention purposes. For practical purposes, this 
can be done at representative sites and assumed 
to be constant across sites. 
Computer and office equipment 
a. Purchase of new computer equipment and 
other office supplies specific to the programme. 
b. Use of existing computer equipment for the 
programme. 
As above. 
Estimation of depreciation cost: These costs 
will be annualised over three years to calculate 
the depreciation cost, discounted at 3% and 5%. 
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Operating costs to be evaluated for the economic analysis of all workstreams 
Fixed and variable operating costs will be considered for all four workstreams. Details of these 
costs and how they should be estimated are presented in the table below. 
Activity-based costing approach 
For staff time operating costs (part of the operating costs), we propose to use an activity-based 
costing approach. This approach allocates activity-based staff time to specific programmes based 
on the proportion of the staff time spent on certain activities. Waters (2006) defines activity-based 
costing in the following way: ‘Activity-based costing essentially defines the principal activities of the 
individuals who work within an organization, then traces costs, first, to these activities, and then 
from the activities to products and services. Human and financial resources within a department 
(production centre) are traced to activities, which are in turn traced to products and services. 
Allocation of personnel time among the activities becomes the principal means for assigning 
overhead and other indirect costs’. 
This approach will be used to allocate costs to specific workstreams for staff who share work 
across several programmes or activities. 
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Table 25: Operating cost elements for CEA of CMAM/IYCF interventions 
Type of cost Cost details Who/what will incur the cost? Cost estimation 
Fixed operating 
costs 
Staff salaries 
Salaries of staff specific to the CMAM/IYCF 
interventions as well as non-programme-
specific staff (shared with other programmes). 
Staff members employed by the IPs and the 
government will be included in the analysis 
based on their share of time. The staff 
members may be in: 
 * Management and administrative roles 
 * Community-based roles (although many may 
be volunteers) 
 * Health facility-based (including nurses, 
doctors, medical assistants, district staff, 
district nutritionists, maternal and child health 
coordinators and health management 
information system officers). 
 * Salaries of international staff and consultants 
 * Salaries of staff members shared with other 
programmes. 
A previously published CEA of the 
CMAM programme (Wilford, 2012) 
suggests that programme-specific 
management and administrative costs and 
international staff costs are incurred 
mainly by the IPs. However, the staff 
salaries of health centre staff and district 
staff are incurred by the government. 
Staff cost attributable to the programme will 
be calculated based on whether staff are 
employed solely (full or part time) by the 
programme or shared with other projects. 
Solely employed staff costs will be equal to 
the salary for staff working only for the 
CMAM/IYCF interventions. For staff 
members with shared work activities, 
proportionate time to CMAM/IYCF 
interventions will be estimated by 
interviewing staff at each level about their 
role share with other programmes, and 
subsequently costing based on time share 
using salary data. 
Any rented facilities/items – to be 
investigated with field staff. 
These can be incurred by government or 
IPs. 
Data on rent paid divided by the time period 
will be used to estimate cost over the period 
of the programme. 
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Variable operating 
costs 
RUTF 
* Cost of all RUTF procured and used during 
the study period should be documented. 
A previous evaluation suggests that these 
costs are incurred mainly by IPs. Any 
government facilities used for this purpose 
(such as warehouses) should also be 
evaluated. 
It should include the cost of purchase, 
transport from the producer’s factory and 
warehousing. Distribution mechanisms will 
be explored before they are costed to avoid 
double counting. 
Medication supplies 
* Including cost of medication and other 
supplies used to treat patients at OTP or SC 
facilities. 
Incurred by government facilities or IPs. 
Programme-specific drug costs will be 
estimated based on supplies 
dispensed/used (or, if these data are not 
available, then supplies purchased). 
Laboratory tests. As above. 
All laboratory tests will be documented for 
each patient and their costs will be obtained 
from the Department of Health. If not 
available, their market price may be 
considered. Alternatively, a micro-costing 
approach may be used at selected facilities. 
Vehicles 
* Cost of repairs and cost of fuel (staff costs 
will be covered in the salaries category). 
Incurred primarily by the IPs. 
Running costs of dedicated programme 
vehicles will be based on financial accounts 
and/or receipts. Cost of shared cars will be 
allocated based on logs recording total 
kilometres driven for CMAM programme 
purposes. 
Utility bills (gas, electric, water, others). As above. 
Taken directly from the financial accounts of 
bill history.  
Training costs, including venue and per diems. As above. 
These will be calculated directly from the 
financial accounting records of IPs. 
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Available/recommended template for collection of cost data 
As mentioned earlier, we are aware of the FANTA costing tool developed by USAID specifically for 
costing CMAM programmes in developing countries. This tool can be very useful in ensuring that 
all line items are captured and a standardised costing practice can be used across all CMAM 
programmes. Below we present a summary of the extensive list of staff salaries that are required 
to be captured by this tool. We propose that this tool is used as much as possible for costing 
purposes.  
Table 26: List of line items required to be collected by the CMAM costing tool developed 
by USAID 
Health care providers and other staff Provided type and functions 
Central HQ 
Senior Central HQ staff (head/deputy head of department) 
Manage and advocate for CMAM at 
national level 
Mid-level Central HQ staff (programme manager) Establish, coordinate CMAM activities 
Group area HQ 
Senior group area HQ staff (graduated nutrition officers – 
more experienced) 
Regional Nutrition Officer – management 
of CMAM 
Mid-level group area HQ staff (technical officers) 
Assistant Nutrition Officer – supervision 
and training of area HQ staff 
Junior group area HQ staff (community health nurse or 
officer at regional level) 
Technical Officer – monitoring/data 
collection and analysis and assisting with 
other management tasks 
Area HQ 
Senior area HQ staff (District Nutrition Officer, who 
graduated within 1–3 years) 
Nutrition Officer (graduate/technical officer) 
– Management of CMAM 
Mid-level area HQ staff (technical officers) 
Technical officers/National service officers 
– Supervision and training at outpatient 
care sites/inpatient care sites 
Junior area HQ staff (community health nurses or officers at 
district level) 
Technical officers/community health 
nurses – Monitoring/data collection and 
analysis and support to mid-level and 
senior staff 
Outpatient care site – Health care providers 
Senior outpatient care staff (senior nurse, medical assistant 
– health facility in-charges) 
Medical assistant/midwifes/clinical nurses 
– management of SAM cases, establishing 
community outreach, training of COWs, 
data management 
Junior outpatient care staff (community health nurses, 
community health officers, and public health nurses) 
Community health nurses – assisting with 
management of SAM cases, supervision of 
COWs, helping establish community 
outreach, data collection 
Community Outreach Worker 
CMAM outreach in the community 
(volunteers)  
Inpatient care site – Health care providers 
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Senior inpatient care staff (clinician, paediatrician, or other 
medical specialist) 
Physician/paediatricians – in-house 
supervision of health care providers, 
managing SAM children with 
complications, data analysis 
Mid-level Inpatient Care staff (clinical nurses, dieticians, 
graduate nutritionist) 
Clinical nurses/graduate dietician/graduate 
nutritionist – day-to-day management of 
SAM in inpatient care, nursing care 
supervision of feeds and preparation, 
monitoring and reporting 
Junior inpatient care staff (health aids, health extension 
workers) 
Health aid/heath extension worker – 
assisting in care of SAM cases with 
complications, preparation of therapeutic 
foods, data collection 
Other workers (all levels) 
Driver 
Driving vehicles carrying supplies or 
people 
Store guard Guarding stores of RUTF 
We propose that patient (carer)-related costs are also captured in this study to reflect the societal 
perspective of the value of the intervention compared to the control. Patient-related costs may 
make up a significant proportion of the total cost of the programme. Below we present a list of 
patient (carer)-related costs that will be captured in the current study. 
Sources of cost data 
Summaries of the sources of the cost data required, as well as some consideration of 
requirements and assumptions, are provided in the tables below.  
Table 27: Sources of cost data, requirements and assumptions 
  Source of data 
Requirements and 
assumptions 
Notes 
Building 
facilities 
Capital cost: Financial 
accounting books and financial 
reports (systems). 
Alternatively, they can be 
estimated according 
to the local market price, using 
current replacement costs. 
 
Service-level activity: Hospital 
and outpatient records 
required to estimate proportion 
of service activity attributable 
to the programme. 
Assumption:  
- Financial accounting 
data exists and is 
accessible. 
- Data on service-level 
activity is available and 
accessible. 
- Technical resources are 
available to carry out 
estimation based on the 
approach described.  
- Qualification: We 
recommend basic 
knowledge of financial 
accounting. 
This type of cost, albeit 
important, is sometimes 
ignored in economic 
evaluations, partly due to 
the difficulty of estimation 
of depreciation costs 
(especially, cost of existing 
facilities). Although this is 
ideal, if it is a challenge to 
collect this cost, the 
approach can be revisited. 
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Equipment 
and furniture 
Same as capital cost sources 
above. 
As above. 
Cost of existing equipment 
and furniture may not be 
available. Hence, 
replacement cost can be 
used and depreciation 
cost applied. 
Vehicles 
As above. In addition, vehicle 
logs will be required. 
Vehicle logs will be 
required. We assume 
that this may be part of 
routine practice or can be 
implemented for 
evaluation purposes, at 
least in selected sites. 
If vehicles logs are not 
available or cannot be 
used, an estimate of the 
proportionate share of use 
of vehicles can be 
obtained by interviewing 
selected programme staff 
and/or drivers at each 
level. 
Computer 
and office 
equipment 
Same as capital cost sources 
above. 
Accounting data will be 
available. 
If not, then data on the 
market price of the used 
models will be available 
or can be estimated. 
Cost of any relevant 
purchases, such as 
software, should be 
included. 
Further sources of cost data were identified through our communication with Dr Kenneth Ojo in 
Nigeria. These are listed below. These sources will be explored with a view to identifying cost-
related data and other inputs for the economic analysis. 
Table 28: Costing studies in Nigeria 
UNFPA/DFID/PATHS2: Report on Costing the Integrated Maternal, Newborn and Child Health Package 
of Interventions 
Harmonized Nigeria Living Standard Survey 2011:  Data collection for poverty analysis using a welfare 
and expenditure approach. 
The Costs and Benefits of a Maternal and Child Health Project in Nigeria, Health Policy Initiative, 
USAID: The Initiative completed interviews with officials from the government, health maintenance 
organisations and development partners, as well as academics and several primary healthcare providers, 
and collected information on the costs of delivering services on NHIS/MDG Maternal and Child Health 
Project and analysed the financial sustainability and incentive structure of the programme design. 
NPHCDA Costing Ward Minimum Health Care Package. It provides an estimate of the cost of providing 
a minimum level of health care package at each PHC and by inference at each ward of Nigeria. 
SMART Nutrition Survey in eight Sahel states of northern Nigeria, 2010/2011; Kano, Jigawa, Katsina, 
Kebbi, Sokoto, Yobe, Zamfara, and Borno. 
Multiple Indicator Cluster Survey 4 (MICS 4) funded by UNICEF Nigeria 2010. The survey collected 
data on maternal and child health care and MDG health indicators. 
Household Baseline Survey by Partnership for Transforming Health Systems 2 (PATHS2) 2010/11, 
2011/12, Collected baseline data for health systems strengthening. 
Baseline Survey on Drug Revolving Fund Programme by PATHS2. 
Core Welfare Indicator Questionnaire Survey. It involves data collection for poverty analysis using a 
welfare approach. 
Outcome measures in the economic evaluation 
The other important aspect of the economic evaluation is the outcome data. These are the model 
parameters that will inform the decision model. These data will be collected through various 
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sources and using different methods. Where possible, we have proposed that data on outcome 
parameters for the economic analysis are collected alongside the impact evaluation. Details of the 
model parameters and their sources are presented below.  
A.2.1.11 Outcome measures for evaluation of the CMAM programme 
Table 29: Model parameters, sources of data and method of data collection 
Model parameters Source Method 
Prevalence of malnutrition 
Prevalence of moderate and 
severe malnutrition in under-
fives in programme evaluation 
areas. 
- The ORIE baseline 
population survey 
(impact evaluation). 
- Random sample of households 
within each LGA. 
- Other sources: 
Demographic and 
Health Survey 
(DHS) of Nigeria 
(report available 
online). 
- Other data sources 
and major reports. 
- Focused literature search for 
published reports/papers based 
on DHS, Nigeria. 
- Further data or reports may be 
available from or through Dr 
Kenneth Ojo’s team at the Centre 
for Health Economics and 
Development, Nigeria (we have 
had direct correspondence 
through Aly Visram). 
Identification and referral to OTP/SC facility in CMAM programme areas 
Probability of identification and 
referral to OTP facility for 
moderate malnutrition in 
CMAM programme 
implemented areas [Pr(OTP)]. 
- The ORIE impact 
evaluation survey. 
- The ORIE impact evaluation 
survey will evaluate the 
malnutrition status of children 
and establish whether or not the 
malnourished patient was 
identified and referred to OTP/SC 
facility through the CMAM 
programme 
- These data will be used to 
estimate the probability of being 
referred to OTP/SC facility, given 
moderate malnutrition. 
Probability of referral to SC 
facility for severe malnutrition 
in CMAM programme 
implemented areas [Pr(SC)]. 
- As above. 
Probability of refusal or default 
without seeking referred care 
in CMAM programme 
implemented areas [Pr(RD)]. 
- As above. 
- As above 
- Alternatively, patient records 
available with the CMAM 
programme community team will 
be evaluated against OTP and 
SC facility attendance data to 
estimate default and refusal 
rates. 
Probability of not identifying 
malnutrition through CMAM 
programme [Pr(notI)] 
 
[Pr(notI)] = 1 – [Pr(OTP) + Pr(SC) + 
Pr(RD)] 
Probability of seeking non-
CMAM programme outpatient 
or inpatient care for 
- As above. 
- The ORIE impact evaluation 
survey. 
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malnutrition among those not 
identified by CMAM 
programme (in CMAM 
programme areas). 
Type of non-CMAM 
programme care sought for 
malnutrition. 
- As above. 
- The impact evaluation survey will 
ask about the kind of non-CMAM 
programme care sought. 
Referral to OTP/SC facility in non-CMAM programme areas 
Probability of seeking 
outpatient care for malnutrition 
in non-CMAM programme 
areas. 
- Same as for CMAM 
programme areas – 
based on data 
collected from 
control sites. 
- Same as for CMAM programme 
areas. 
Type of outpatient care 
sought. 
- As above. 
- The impact evaluation survey will 
ask about the kind of non-CMAM 
programme care sought. 
Probability of referral 
(including self-referral) to 
inpatient care for malnutrition 
in non-CMAM programme 
areas. 
- As above. - As above. 
Outcome of care at OTP facility in CMAM programme areas 
Probability of being cured 
during treatment at OTP 
facility/community-based 
treatment. 
- CMAM programme 
data. 
- Routine data collection system 
will be put in place to collect 
patient-level data for all children 
seeking care at OTP facility over 
a period of 12 months (preferably 
once the programme is well 
established).  
- The database should collect the 
following outcome data for each 
patient seeking care at OTP 
facility: cured, referred to SC, 
died or refusal or discontinuation 
of treatment, revisit during the 
12-month period for malnutrition. 
Probability of death during 
treatment at OTP/community-
based treatment. 
- As above. 
Probability of referral to SC 
facility during treatment at 
OTP facility. 
- As above. 
Probability of refusal or 
discontinuation of treatment at 
OTP facility. 
- As above. 
Outcome of outpatient care in non-CMAM programme areas 
Probability of being cured 
during outpatient treatment in 
non-CMAM programme areas. 
- Data from non-
CMAM programme 
facilities. 
- A routine data collection system 
will be established for control 
OTP facility area/s and the 
abovementioned data should be 
collected. 
Probability of death during 
outpatient treatment in non-
CMAM programme areas. 
- As above. 
Probability of referral to SC 
facility during treatment at 
OTP facility. 
- As above. 
Probability of refusal or 
discontinuation of non-CMAM 
- As above. 
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programme outpatient 
treatment in non-CMAM 
programme areas. 
Outcome of SC facility care in children directly referred to SC facility through CMAM 
programme 
Probability of being cured 
during treatment at SC facility. 
- Hospital routine 
data. 
- A routine data collection system 
will be put in place to collect 
patient-level data for all children 
seeking care at SC over a period 
of 12 months (during the same 
period when data from OTP 
facilities are being collected).  
The database should collect the 
following outcome data for each 
patient seeking SC care: cured, 
referred to OTP facility, died or 
refused or discontinued treatment. 
Probability of death during 
treatment at SC facility. 
- Hospital routine 
data. 
Probability of refusal or 
discontinuation of  treatment at 
SC facility. 
- Hospital routine 
data. 
Outcome of care at SC facility for non-CMAM programme patients/areas 
Probability of being cured 
during treatment at SC facility. 
- Hospital routine 
data. 
- As above. 
Probability of death during 
treatment at SC facility. 
- Hospital routine 
data. 
Probability of refusal or 
discontinuation of treatment at 
SC facility. 
- Hospital routine 
data. 
 
Below we summarise the main categories of data that will be required for the economic evaluation 
(as presented in detail above), and the sources/studies proposed in this design document. 
A.2.1.12 Outcome measures for evaluation of the IYCF interventions 
As discussed in the methods section, the outcome measures for the economic evaluation of the 
IYCF interventions are the same as the outcome measures of the impact evaluation, i.e. young 
children and infant feeding related outcomes. These outcomes will be converted into probabilities 
of health consequences (as discussed earlier) and subsequently converted into DALYs. Hence, 
the outcome data for the evaluation of IYCF interventions will come from the impact evaluation 
exercise. 
Sampling strategy for data collection (cost and outcome data) 
In order to get a representative sample of the population to reflect the costs and outcomes 
associated with the programme, we propose that variation across states and between LGAs within 
states should be considered. With regards to the economic evaluation, the functional 
capacity/performance of the healthcare system, level of disease burden, socioeconomic gradient 
and cultural differences are among the variables of interest.  
For the impact evaluation exercise, stratified random samples of households will be collected from 
four states, i.e. Zamfara, Jigawa, Kebbi and Katsina. Within each state, two or three LGAs will be 
selected and then households will be randomly selected within each LGA. The expected sample 
size for each state is 500 households for the intervention group and 500 for the control group 
within each state. 
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We have had a detailed discussion with Dr Kenneth Ojo of the Centre of Health Economics in 
relation to variability across states and between LGAs to achieve a representative sample in terms 
of variability in the factors outlined above. Based on this, we propose the following: 
1. Cost and outcome data are collected from two states only, Jigawa and Zamfara. Jigawa is 
in the North East while Zamfara is in North West of Nigeria. Jigawa has relatively better 
health indicators compared to other northern states of Nigeria and much better compared 
to Zamfara.  
2. Within each state, we propose that random samples of households are drawn from all three 
LGAs following the same strategy as the impact evaluation. Taking this approach would 
ensure that sufficient variation in health services, socioeconomic gradient and other 
regional variations will be captured. Hence, the household survey will be conducted using 
the same sample as the impact evaluation within the chosen LGAs. Both intervention and 
control households will be included in the sample, in line with the impact evaluation. The 
sample size used within each state for the impact evaluation will be sufficient for the 
economic evaluation. 
3. For facility-based data collection (for programme-related costs and facility-based patient 
outcome data for CMAM programme; see below), the same strategy will be used as above. 
Hence, three LGAs will be selected from Jigawa and Zamfara. Within each LGA, we 
recommend that two health facilities are selected, one from the intervention area and one 
from control area. These health facilities should be close to each other in terms of 
rural/urban characteristics and socioeconomic status (and, possibly, disease burden). 
The following data will be collected from the proposed states and LGAs: 
1. Programme-related capital and operating costs, including all the costs identified in Table 23 
and Table 24. This relates to all four workstreams. Areas of shared resources should also 
be identified so that double counting can be avoided if a combined evaluation is conducted. 
These costs will be collected once for the health facilities (as discussed above). 
2. Facility-based data collection: Outcome data for patients who used outpatient and inpatient 
facilities during a period of one year (i.e. during a one-year period when the programme is 
fully operational – preferably year 2 or year 3 to allow for data analysis and modelling work) 
– this will be used in the evaluation of the CMAM programme workstream. The outcome 
data for the IYCF interventions analysis will come from the household survey conducted as 
part of the impact evaluation. 
3. Facility-based data collection: Patient-related cost data will be collected to capture direct 
and indirect resource use, including opportunity cost (discussed later). These may be 
collected using a questionnaire-based survey or based on focused group interviews 
(recently used for the economic evaluation of CMAM in Bangladesh). As above, these data 
will also be collected in a cross-sectional manner, i.e. patients will be asked once about 
health-related costs. 
4. Household survey data: Outcome data will be collected to be used for the evaluation of 
workstreams 1 and 2. This will be an add-on to the impact evaluation exercise and will be 
collected at baseline and follow-up. 
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Timing of data collection 
We propose the following timetable for data collection: 
1. Programme delivery costs will be collected from intervention and control areas once the 
programme is fully operational, which is likely to be between years 2 and 4. However, to 
allow time for data analysis and economic modelling, we would propose that programme 
delivery costs are collected during year 2 or year 3. 
2. Facility-based outcome and cost data from patients should cover a period of one year for 
all patients admitted to health facilities during the one-year period. Using the same 
argument as above, we propose that this data is collected during year 2 or year 3 of the 
programme. In order to spread the data collection process, it may be feasible to collect 
programme delivery cost data during year 2 and facility-based outcome and cost data 
during year 3. Year 1 will allow preparation time for data collection. 
3. Household survey data: This will be conducted in line with the impact evaluation exercise. 
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Annex B Literature on the cost-effectiveness of CMAM 
This section presents a summary of the cost-effectiveness evidence on the CMAM intervention. 
This literature helped inform the study design, model parameters and assumptions used in the 
economic evaluation of CMAM in Nigeria. 
These studies were conducted mainly in South/ South-East Asia and sub-Saharan Africa. The 
literature review provides useful insights into the methods for our cost-effectiveness study, not 
least because both societal and health services perspectives have been used in this literature. 
Published studies have used the following comparators: (1) inpatient facility-based care; (2) 
existing health services without CMAM; or (3) do nothing. Comparator (2) includes inpatient care 
as well as outpatient care. This approach was taken by Wilford et al. (2012) in Malawi. 
Most of the published studies have captured a broad range of cost centres, including capital costs 
(such as purchase of vehicles and equipment, and building costs), recurrent costs (including 
overhead costs, staff salaries and utilities), and cost of therapeutic food and medication. Only a 
few studies have considered the cost for the caregiver, including out-of-pocket expenditure and the 
opportunity cost of seeking care. 
Another aspect of the CMAM evaluation is how model parameters were obtained for non-CMAM 
control areas. Puett et al. (2013) estimated the probability of inpatient care in the comparator arm 
using primary data on the proportion of total SAM cases (identified by community health workers in 
the community) who were referred and subsequently used inpatient care. However, Tekeste et al. 
(2012) directly compared patients treated in CMAM community-based therapeutic centre versus 
non-CMAM inpatient care using data collected in these facilities; this approach ignores differences 
in coverage/referral and probability of use of the two interventions by directly comparing resource 
use and outcomes of patients actually using the facilities. Finally, Wilford et al. (2012) used existing 
non-CMAM health services as the comparator, and assumed that one in four SAM cases received 
SC in control areas, while three in four received a set of three clinic visits. They then conducted 
sensitivity analyses with +/-25% of base case costs. 
Finally, both cost per child treated and cost per DALY have been used to report final results of the 
study. There is huge variability in cost per child treated, which can be explained by the differences 
in the cost centres included in the analysis. The two relatively robust studies in our review, in terms 
of data and analysis, found cost per child treated to be $169.3 in CMAM areas and $16.7 in non-
CMAM area (Wilford et al., 2011), and $165 per child treated by CMAM and $520 per child treated 
by inpatient treatment (Puett et al., 2013). In these studies, while cost per child treated is similar in 
CMAM areas, it is significantly different in non-CMAM areas ($520 vs $17 per child treated). This is 
primarily due to differences in the treatment received in control areas. Wilford et al. use existing 
health services (without CMAM) as the comparator, while Puett et al. use more expensive inpatient 
care as the comparator. Using inpatient care as the comparator implies that CMAM is likely to be 
relatively cheaper. However, the direction of difference in effect between the more expensive non-
CMAM inpatient care and the OTP/SC facility pathway may be less straightforward to predict – this 
is because children using inpatient care often tend to be sicker (with worse prospects); on the 
other hand, inpatient care may be better at treating SAM (assuming the same level of sickness) 
and have a better treatment effect.  
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Table 30: Summary of published economic evaluation studies on SAM in children 
Study Country 
Type of 
analysis 
Perspective Comparator 
Costing 
approach 
Cost elements 
Cost per child 
treated 
Cost per 
DALY 
averted 
Cost per 
death 
averted 
Abdul-Latif 
and 
Nonvignon 
(2014) 
Ghana Cost analysis Societal None 
Traditional 
expenditure-
based 
costing 
Vehicles purchase 
Equipment 
purchase 
Staff salaries 
Vehicle operation 
Training cost 
Job aids 
Monitoring cost 
Building rent 
RUTF 
$805.36 per 
child detected 
and treated 
- - 
Puett et al. 
(2013) 
Bangladesh 
Cost-
effectiveness 
Societal 
Inpatient 
treatment 
(facility-
based) 
Activity-
based 
costing 
Monitoring cost 
Training cost 
Supervision cost 
Growth Monitoring 
and Promotion 
sessions 
Household visits by 
CHWs 
Curative care 
Community 
treatment = 
$165 per child 
Inpatient 
treatment = 
$520 per child 
Community 
treatment = 
$26 
Inpatient 
treatment = 
$214 
Community 
treatment = 
$869 
Inpatient 
treatment = 
$7,276 
Purwestri 
et al. 
(2012) 
Indonesia 
Cost analysis 
(with some 
outcomes 
presented 
separately) 
Societal None 
Traditional 
expenditure-
based 
costing 
Capital costs 
Staff salaries 
Transportation 
Incentives for 
voluntary workers 
Food supplements 
Haemoglobin and 
health assessment 
Daily 
programme: 
US$376.2 per 
child 
Weekly 
programme: 
US$331.8 per 
child 
- - 
Tekeste et 
al. (2012) 
Ethiopia 
Cost-
effectiveness 
Societal 
Inpatient 
treatment 
(facility-
based) 
Traditional 
expenditure-
based 
costing 
All personnel 
salaries 
Capital 
depreciation 
Utilities 
Medicines 
RUTF/milk-based 
formula 
Therapeutic 
Feeding Centre: 
$262.62 
(institutional) 
and $21.01 
(opportunity 
cost) per child 
treated  
- - 
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Caretakers' food 
Non-food and other 
supplies 
Community-
based 
therapeutic care 
:$128.58 
(institutional) 
and $5.87 
(opportunity 
cost) per child 
treated 
Wilford et 
al. (2012) 
Malawi 
Cost-
effectiveness 
Health 
Services 
Existing 
health 
services 
without 
CMAM 
Traditional 
expenditure-
based 
costing 
Capital costs: cars, 
motorbikes, 
computers 
Recurrent costs: 
RUTF, admin cost, 
direct staff cost, 
transport, training 
cost, medical 
supplies, inpatient 
cost 
CMAM area = 
$169.3  
Non-CMAM 
area = $16.7 
$42 per 
DALY 
averted 
(base case) 
$493 per 
DALY 
averted 
(worst case) 
$1,365 per 
death 
averted 
Bachmann 
(2009) 
Zambia 
Cost-
effectiveness 
Health 
Services 
Do nothing 
Traditional 
expenditure-
based 
costing 
Cost of health 
centre visit 
Cost of RUTF 
Cost of community 
mobilisation 
CTC = $203 per 
child 
No treatment = 
$0 
$53 per 
DALY 
averted 
$1,760 per 
death 
averted 
Ashworth 
and 
Khanum 
(1997) 
Bangladesh 
Cost-
effectiveness 
Societal 
i) Inpatient 
care 
ii) Day care 
Traditional 
expenditure-
based 
costing 
Staff salaries 
Capital 
depreciation 
Utilities 
Laboratory costs 
X-ray cost 
Medicines/supplies 
Child's food 
Carer's food 
Inpatient = $159 
Day care = 
$63.8 
Domiciliary = 
$38.8 
- - 
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Annex C Literature on economic evaluations of IYCF 
interventions 
This section presents a summary of the economic evidence on the IYCF intervention. 
The study by Chola et al. (2011) was conducted in Uganda, while that of Nkonki et al. (2014) was 
conducted in South Africa. Both studies were conducted by the PROMISE-EBF and used similar 
methodology by costing the PROMISE-EBF intervention, which was evaluated in a cluster 
randomised trial. The intervention involved offering support provided by peer-supporters who 
recruited pregnant women who come for routine ANC, established their feeding practices and then 
supported them in breastfeeding practices. Peer support workers were supervised by one 
supervisor per site, who supported 10–14 peer-supporters. 
Both studies conducted an economic evaluation from the provider’s perspective and excluded any 
costs incurred by mothers. Costing of the project was done using the budget and expenditure data 
of PROMISE-EBF programme. For other goods, market prices were used in the absence of 
available primary data. 
The studies found that cost per mother counselled was US$139 and US$228 in Uganda and South 
Africa respectively, while cost per visit was US$26 and US$52 respectively in the two countries. 
Chola et al. (2011) also report the cost per week of EBF as US$15 per week. Overall, costs in 
South Africa were higher than costs in Uganda, which is due to higher cost structures in South 
Africa. For instance, community health workers are remunerated at the rate of US$152 per month 
compared to only US$20 per month in Uganda. 
The main limitation of these studies is that they did not model long-term outcomes, either in terms 
of reduced mortality, morbidity (for instance, infection rates) or a combined measure of mortality 
and morbidity, such as DALYs. Both studies report intermediate outcomes, such as number of 
visits or number of weeks of EBF. However, to allow comparison between interventions and across 
health conditions, it is important to express health benefits in terms of generic health outcomes. 
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Table 31: Summary of published economic evaluation studies of feeding practices in children under 2 
Study Country 
Type of 
analysis 
Perspective Intervention Comparator 
Costing 
approach 
Cost elements Results 
Chola et al. 
(2011) 
Uganda Cost analysis 
Health 
provider 
Individual 
peer support 
counselling 
intervention 
None 
Activity-
based 
costing and 
an 
ingredient 
approach 
Start-up 
Travel 
Manual adaptation and 
initial training 
 
Overheads 
Communication 
Utilities 
Office rent 
 
Peer support 
Personnel cost 
Bicycles 
Field materials 
 
Peer supervision 
Personnel cost 
Transport cost 
Supervisory meetings 
Office supplies 
Capital costs 
Cost per mother 
counselled was 
US$139 
Cost per visit was 
US$26 
Cost per week of EBF 
was estimated to be 
US$15 at 12 weeks 
postpartum. 
Nkonki et 
al. (2014) 
South 
Africa 
Cost analysis 
Health 
provider 
Individual 
peer support 
counselling 
intervention 
None As above As above 
Cost per mother 
counselled was 
US$228 and cost per 
visit was US$52. In an 
operational ‘non-
research’ scenario, 
these were US$137 
and US$32 per 
mother and per visit, 
respectively. 
 
